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1. Abstract

Healthcare outcomes research based on administrative data is frequently
hindered by two important challenges: (1) accurate adjustment for disease burden and
(2) effective management of missing data in key variables. Standard approaches exist
for both problems, but these may contribute to biased results. For example, several wellestablished summary measures are used to adjust for disease burden, often without
consideration for whether other methods could perform this task more accurately.
Similarly, observations with missing values are often arbitrarily excluded, or the values
are imputed without regard for the involved assumptions. Despite recent substantial
gains in computing power, statistical approaches and machine learning methods, no
comprehensive effort has been made to develop an improved comorbidity index based
on predictive performance comparisons of competing approaches. Similarly, recently
developed machine learning approaches have shown promise in addressing missing
data problems, but these have not been compared with parametric methods via a
rigorous simulation study using large-dimensional data with the complete range of
missingness types. This makes it difficult to assess the relative merits of each
procedure.
This work accomplished three broad aims: (1) Improved models for summarizing
disease burden were developed by comparing the predictive performance of a wide
vii

variety of statistical and machine learning methods. (2) A new comorbidity summary
score for predicting five-year mortality was developed. (3) A comprehensive comparison
of machine learning and model-based multiple imputation methods was completed, both
in simulations and through an application to real data. Several sensitivity analyses were
also examined for variables with missing not at random (MNAR) missingness.
This work successfully demonstrated several new approaches for summarizing
disease burden. Each of the competing disease burden models in the first aim and the
summary score from the second aim had superior predictive performance when
compared to the Elixhauser index, a commonly-used summary measure. This research
also led to new applications for applying machine learning methods within the multiple
imputation with chained equations (MICE) framework. Additionally, several MNAR
sensitivity methods were adapted and applied to demonstrate that unbiased inference
under MNAR may not be possible in some situations, even when the missingness
mechanism is fully understood.
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2. Introduction

2.1 Motivation
The motivation for this research came from my work in the Veteran’s Health
Administration’s (VHA) Health Services Research and Development (HSR&D) Center of
Innovation (COIN) for Health Equity and Rural Outreach, located in Charleston, South
Carolina. This group works to reduce disparities in healthcare access and outcomes
between Veterans due to racial, ethnic, geographic, or gender-based differences. Much
of this research involves observational studies based on VHA and Medicare
administrative healthcare datasets, which typically involve millions of patients, each of
whom may have thousands of observations involving demographic information,
diagnostic and procedure codes, laboratory results, pharmacy records, text notes, and
cost data. Most studies are forced to deal with two key challenges:
1) Models examining differences between groups must accurately account for each
patient’s disease burden by summarizing information contained in diagnostic
codes, for which there are thousands of unique values.
2) Many patients are missing data in key variables that are essential for making
any valid inference concerning disparities, such as the race/ethnicity variable.
Further compounding the challenge, the pattern for such missingness is often not
random.
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Standard approaches exist for both problems, but these may risk contributing to
biased results. For example, investigators often use the Charlson or Elixhauser
Comorbidity indices [1, 2] to summarize a patient’s disease burden from the information
collected from thousands of covariates, but they may do this without regard for the
assumptions and limitations associated with these measures. When dealing with missing
data, some investigators exclude observations with missing values and only consider
complete cases, while others impute values using models that are based on missing-atrandom (MAR) assumptions. Either option could lead to bias, particularly since
missingness patterns for some important variables in VHA data likely violate this crucial
MAR assumption [3 – 6] .
In developing better approaches for these challenges, it was important to
consider the full range of available methods, and to consider whether approaches that
combined the strengths of several methods might produce superior results. For example,
substantial advances in computing power, statistical and machine learning methods
since the Elixhauser index’s development in 1998 could support the development of an
improved summary measure, perhaps one based on the combined predictions of several
methods. Similarly, statistical and machine learning methods each bring different
strengths to the missing data problem.

2.2 Specific Aims
2.2.1 Aim 1
Using two large Veteran’s Health Administration cohorts involving diabetes and
traumatic brain injury, develop improved models for summarizing disease burden from
2

large-dimension binary diagnostic features data by training and validating models based
on a wide variety of statistical and machine learning methods for variable selection and
dimension reduction, including a model based on the pooled predictions of the other
models. Compare each method’s predictive performance with existing scores using
AUC, sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV), and net reclassification improvement statistics for events and non-events. Include
methods from the following broad categories:
a. Generalized linear model and regularized regression approaches:
(i) Model-Averaged Regression Coefficients (MARC)
(ii) Probability Based Features (PBF).
(iii) Penalized generalized linear model (elastic-net)
b. Machine learning methods:
(i) Association Rules Analysis (unsupervised method)
(ii) Random Forest (supervised method)
c. Bayesian methods (includes machine learning approaches)
(i) Naïve Bayes variable selection (Multi-morbidity Index)
(ii) Bayesian Additive Regression Trees
Compare model performance for several mortality outcomes, by applying several
methods of establishing baseline comorbidities, and by validating models on both singledisease populations and combined populations.

2.2.2 Aim 2:
Develop a new comorbidity summary score for predicting five-year mortality based on
variable importance measures from the top-performing models in the first aim. Train and
validate these models using three large VA cohorts with diabetes (DM), chronic kidney
disease (CKD), or a history of traumatic brain injury (TBI). Compare the score’s
3

performance to the Elixhauser-Quan index using AUC, sensitivity, specificity, Brier
Index, and net reclassification index statistics. Determine if the new score provides any
population insights beyond those provided by the existing Elixhauser-Quan index.

2.2.3 Aim 3
Compare machine learning and model-based multiple imputation methods for dealing
with missing covariate data under missing at random (MAR) and missing not at random
(MNAR) scenarios. For MNAR situations, also examine sensitivity analysis approaches
to determine whether unbiased imputation is possible in typical missing data scenarios
seen in VA research. Evaluate imputation performance using simulations and by
application to VA traumatic brain injury data using relative bias, root mean squared error,
efficiency, and coverage probability statistics.

2.2.4 Aim 4:
Publish the R and SAS program code used in each aim on GitHub, along with a
simulated dataset that can be used to demonstrate its function.

2.3 Background
2.3.1 Diagnostic code system
In administrative healthcare data, comorbidity information can be found in
numerous forms, including physical exam notes, laboratory results and pharmacy
records, but this work is focused on that information encoded by the International
Classification of Diseases, Clinical Modification (ICD-9-CM or ICD-10-CM), or by a
4

similar system. These variables consist of 5-digit hierarchical codes, where codes
sharing the first three or first four digits are likely to involve related diseases. This
hierarchy creates a correlation structure within these data, yet the methods commonly
used to model disease burden in ICD-CM data do not account for this structure; nor do
they attempt to account for any unidentified interactions. Figure 1 shows the hierarchy
for hypertensive chronic kidney disease within the ICD-9-CM system. All codes
associated with this condition share the first three digits, while the fourth digit in this
example indicates whether the disease is benign, malignant, or unspecified. The fifth
digit further classifies the disease.

Figure 1: Example hierarchy for the ICD-9-CM system. CKD is chronic kidney disease, and ESRD
is end stage renal disease.

2.3.2 Existing comorbidity summary measures
There are several well-known comorbidity summary measures based on the ICD
system. The Charlson Comorbidity Index is a score based on the sum of seventeen
weighted comorbidities [1]. Deyo et al., Romano et al., Quan et al. and others developed
closely-related indices; the newer versions were based on the ICD-9-CM system and
thus could be directly applied to administrative databases [7 – 9]. Elixhauser et al.
5

developed a less parsimonious ICD-9-CM approach for predicting in-hospital mortality
that defined 31 comorbidities [2]. Elixhauser excluded numerous conditions such as
those related to the primary diagnosis, acute complications related to treatment, or those
considered to be unimportant. The Elixhauser index was shown in several studies to be
more effective than the Charlson Index in predicting in-hospital mortality and one-year
mortality [2, 9, 10] and today remains one of the most commonly used comorbidity
indices based on the ICD system. Quan et al. developed enhanced indices that
corrected inconsistencies in earlier algorithms and provided better accounting for the
ICD taxonomy, which can frequently lead to the same condition being coded in multiple
ways.
Van Walraven et al. [11] sought to derive a single score to represent the 31
independent Elixhauser comorbidities, such that it might be easier to develop more
parsimonious models, particularly for small populations. This approach produced
weights for each comorbidity based on the relative magnitude of predicted coefficients
from a multivariate logistic model. Though the authors concluded that neither the
summary score nor the original Elixhauser index was effective in predicting in-hospital
mortality, they demonstrated their score’s predictive ability was as effective as the
original Elixhauser index in adjusting for comorbidities based on the comparison of AUC
statistics in a dataset of approximately 345,000 hospital admissions.
Quan’s enhanced version of the ICD-9-CM Elixhauser index is used throughout
the first two aims as the primary basis for comparison since it was shown to have
superior predictive performance over the earlier versions of the Elixhauser index [9], and
since the van Walraven score was shown to offer no additional advantage. Further
6

reference to the ‘Elixhauser Index’ throughout this work thus refers to the Quan
enhanced version of the ICD-9-CM Elixhauser Index unless otherwise indicated.
Alemi et al. developed an ICD summary score called the multi-morbidity index
based on an application of the Naïve Bayes classification model [12]. This index was
applied in several large Veteran’s Administration populations [13] to predict mortality
within 6 or 12 months, and the authors compared prediction performance against models
based on the Quan variant of the Charlson index and the van Walraven variant of the
Elixhauser index. The AUC for the multi-morbidity index predicting 6-month mortality was
0.784, compared with values of 0.652 and 0.639 for the Quan-Charlson and van
Walraven Elixhauser measures. Although this represents a substantial improvement, the
authors do not demonstrate whether the Naïve Bayes approach was the best for binary
ICD data, or whether other statistical or machine learning approaches might produce
superior results.

2.3.3 Choice of classification models
The first two aims both involve problems of classification. In the first aim, for
mortality outcome ( y1 ,..., yn ) and binary ICD-9 predictors ( x1 ,..., x p ) , the goal is to find
an unknown function capable of predicting the outcome: y = f (x). In the second aim, the
challenge is similar, except that the ICD-9 binary predictor matrix is replaced by a single
summary score for each patient. Existing comorbidity measures such as the Elixhauser
or Charlson indices were developed using traditional statistical methods (logistic
regression and Cox proportional hazards models) with input from clinicians for decisions
on whether to include or exclude various conditions [1, 2]. In order to produce models
7

with improved classification performance, numerous approaches were considered,
including statistical models, machine learning algorithms, and Bayesian methods which
incorporated both statistical and machine learning elements. Although there were
dozens of methods to consider (see Hastie et al [14]), the intent was to adapt and test as
many as feasible, with the goal for finding those with the best classification performance
in ICD-9 data, and with the additional goal for finding a collection of methods which
succeeded due to dissimilar strengths. For example:
1) Some statistical models may succeed based on their ability to account for the
correlation structure in ICD-9 data. These data are characterized by hundreds of
binary features, many of which are sparse, and many are correlated with other
features. This correlation could be due to the hierarchical structure imposed by
the ICD system; in other cases it could be due to associations between disease
conditions not found within the same hierarchy.
2) Machine learning methods may succeed due to their ability to automatically
account for unknown interactions and non-linear relationships between predictors
[15 – 18].
3) Methods based on an ensemble of models may be more successful. Dietterich
[19] provided a justification for the observation that ensembles of accurate and
diverse classifiers often perform better than the individual models. While his work
helps to explain the success of several machine learning methods, it also justifies
a model based on the pooled predictions of the successful statistical and
machine learning methods from the first aim. Dietterich defined an accurate
classifier as one with an error rate lower than that based on random guesses;
8

diverse classifiers are those with different error rates for the same data. He
provided three reasons why an ensemble often provides better results than the
individual classifiers [19]. First, given a hypothesis space, H , each classifier
provides a hypothesis, with errors associated with the model’s inherent
characteristics and with the amount of training data provided. When the votes of
many classifiers are combined, the overall accuracy will likely improve if the
classifiers are truly diverse. Next, models based on searches over the hypothesis
space may become fixed on local optima, and an ensemble of models with
different search paths will likely provide a better overall solution. Finally, although

H theoretically contains all possible hypotheses, its size is in practice limited by
the training data’s dimensions such that the true classification function might be
excluded from H . When the results of numerous models are combined, perhaps
in a weighted sum, it may be possible to expand the hypothesis space such that
the true classification function is found.

2.3.4 Establishing baseline disease burden
Each aim involves observational data in which patients were included at the start
of the study if they met diagnostic criteria for the primary disease (diabetes, chronic
kidney disease, or traumatic brain injury), and additional patients entered each year of
the study as they first met the same criteria. Patients were followed until death or the
end of the study. There was no “dropout” category: patients who had no in-patient or outpatient visits in a given year were assumed to be alive unless a date of death was found.
In many cases an exact diagnosis date was unknown. For example, in TBI patients, the
9

original injury may have occurred in combat, and the injury date would likely only be
found in the patient’s Department of Defense medical record, which was not available in
this study. Similarly in other cohorts, the original diagnosis may be recorded by another
healthcare system. Given these limitations, mortality outcomes were defined based on
how many years the patient lived after entering the study. Each patient’s set of unique
ICD-9 codes were collected from the earliest entry in the patient’s VHA record until an
appropriate cutoff point before death, or until the study’s end, as applicable. For five year
mortality, this cutoff was arbitrarily set as follows:
1) If the patient died within five years of entering the study, the cutoff was set at one
year prior to death. This excluded codes for conditions that typically occur just
prior to death, such as palliative care; these conditions are highly associated with
the outcome but are of less use in making long-term predictions.
2) If the patient died after being in the study for more than five years, the cutoff for
ICD code collection was set at five years after study entry.
3) If the patient did not die during the study, the cutoff was set at the study’s end
date.
Figure 2 illustrates these limits for two patients (A and B). Regions shaded in red are
ICD-9 code collection periods for patients A and B. Patient A entered the VA system in
1985 and entered the study in 2000; patient B entered the VA system in 2003 and
entered the study at the same time. Patient A died within 5 years of the study’s start
date, while patient B was still alive 5 years after entering the study and was recorded as
“alive” in the five-year mortality variable. Patient B’s ICD code collection stopped five
years after he or she entered the study. The two patients may have substantially
10

different total numbers of ICD codes, and the challenge for the models was similar to
asking, “given everything in the record up until this point, what is the probability the
patient actually died within five years of entering the study?” For the models to provide
good predictions, the presence of more or less information for a given patient should not
lead to bias in either direction. The comparison models based on the Elixhauser index
faced the same challenge. While there are several possible ways to establish the limits
described here, this method was found to produce reasonable results.

Figure 2: Establishing five year mortality and ICD-9 collection periods for a study running between
2000-2015.

2.3.6 Evaluation of model performance
2.3.6.1 Evaluation of classification models (Aims 1 and 2)
Area under the receiver operating characteristic curve (AUC), sensitivity,
specificity, positive predictive value (PPV) and negative predictive value (NPV) were all
considered when comparing models. The net reclassification improvement (NRI) statistic
11

for events (patients who died) and non-events (patients who lived) was also considered
[20]. NRI statistics for the Elixhauser models are not provided since they form the
reference. While NRI statistics have been widely adopted, Pepe et al. [21] showed they
should be used with caution. In particular, the authors demonstrated that positive NRI
results could be achieved in some situations where the new model involved an added
variable with no predictive value, possibly due to poorly fitting risk models. The AUC and
related ROC statistics provided reliable results in these situations. Primary emphasis
was thus placed on the AUC and related statistics; in particular, the NRI result was not
claimed as evidence for prediction performance improvement unless similar gains were
seen in the AUC. Finally, the Brier Score provided a measure of misclassification error or
mean-squared error for binary outcomes [22].

2.3.6.2 Evaluation of multiple imputation models (Aim 3)
Imputation methods were compared using the following statistics:
1) Relative bias: (ˆ  ˆ ) / ˆ , where ̂ and ˆ o are the generalized linear model
o

parameter estimates based on the imputed data and the full dataset of complete
cases, respectively.
2) Efficiency: var(ˆ )/ var(ˆ )
o

3) Root mean square error:

( ˆ  ˆ o )2  ˆ 2 , where ˆ 2 is the estimated variance of the

parameter estimate from the model based on imputed data.
4) Coverage probability: the probability based on 1000 bootstrapped iterations that the
95% confidence interval for the parameter estimate contains ˆ o .
12

2.3.7 Missingness in VHA data
Missing data in key VHA variables such as race/ethnicity poses a substantial
problem for investigators involved in healthcare inequities. Further, several investigators
have reported missing race information in VHA or Medicare data may not be missing at
random [4 – 6]. Depending on the timeframe being studied, the level of missingness may
be substantial. Stroupe et al. [23] reported that 48% of VHA patient records had missing
race-ethnicity information in 2004, but this value had been reduced to 15% by 2012 [3]
due to concerted efforts to collect this information and due to a 2003 requirement for
recording self-reported race-ethnicity rather than observer-reported values [24]. Stroupe
et al. [23] demonstrated that further improvements were possible by merging VHA data
with Medicare data; in the author’s experience with several VHA cohorts followed
through 2012 or later, the missing race fraction can now be reduced to below 5%.
However, the missing race-ethnicity problem is far from solved: even at these lower
levels, if the data are believed to be missing due to non-random processes, investigators
must still be concerned whether unbiased results were achieved. Further, studies
involving patients who were not followed in recent years will likely still face substantial
missing data problems.
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2.3.8 Existing multiple imputation methods
In past years, researchers often dealt with the missing data problem by simply
conducting complete-case analysis, though this strategy could lead to biased results
unless the data were missing completely at random. More recently, steps to attempt to
assess the pattern of missingness and methods to help achieve unbiased results are
commonly seen. Numerous parametric imputation methods exist for handling data with
missing completely at random (MCAR) or missing at random (MAR) patterns; multiple
imputation with by chained equations (MICE) is one commonly used approach due to its
ability to handle multiple imputation for mixed data types [25, 26]. MICE imputes missing
values from separate conditional distributions for each variable with missing values, but
has been criticized for lacking a theoretical basis [27], and for requiring the investigator
to have advance knowledge of non-linear relationships or collinearities between
predictors [17]. Other researchers have concluded that machine learning methods can
automatically handle interactions and other concerns while also producing inference
estimates with narrower confidence limits and with more computational efficiency. The
random forest algorithm has been applied in several multiple imputation research efforts,
and involves bootstrap aggregation of numerous independent decision trees, and can
account for complex interactions and collinearities between predictors more readily than
many parametric methods, while the ensemble voting of independent trees naturally
lends itself to an efficient imputation process [28]. For example Stekhoven et al. [16]
claim their multiple imputation approach (missForest) based on the random forest
method was superior to traditional statistical methods including MICE, based on
improved misclassification error rates or normalized root mean squared errors. Jerez et
14

al. [29] provided a similar conclusion based on a comparison of machine learning and
statistical imputation methods. Other researchers have incorporated machine learning
methods within an existing statistical method. For example, Shah et al. [17] incorporated
random forest as the multiple imputation method within the existing MICE method and
showed the new approach had a superior ability to handle nonlinear relationships and
collinearities.

2.3.9 Evaluating missing not at random (MNAR) situations
Though the multiple imputation methods described above are capable of
producing unbiased results under MCAR and MAR, such results are far less likely under
MMAR. As Verbeke et al. [30] discuss, it is possible to construct models based on
MNAR assumptions, but these assumptions are not testable since their support is not
contained in the data. Further, Molenburghs et al. [31] demonstrated that it is not
possible to empirically distinguish between MNAR and MAR situations from the data
alone because for every MNAR model, it is possible to build an MAR model with the
same fit. The most common approach given these circumstances is to conduct
sensitivity analysis on MAR models to examine their stability when MNAR assumptions
are introduced [32, 33] Though numerous approaches are possible, two general types of
sensitivity analyses are most common; these are based on pattern mixture models [32 –
34] and selection models [35].
A pattern mixture model assumes that a number of missingness patterns may
exist, each with a separate joint distribution for the partially and fully observed variables.
For patients i 1,...,n and covariates Y1i and Y2i , assume Y1i has missing values with
15

indicator Ri , such that Ri

0 when Y1i is missing and Ri

0 otherwise. Under MNAR the

joint distribution f (Y1i ,Y2i ,Ri ) is factored as f (Y1i ,Y2i | Ri ) f(Ri ) , where the joint distribution of
the partially and fully observed variables is conditional on the partially observed variable.
Since the MNAR distribution cannot be determined from the observed data, Carpenter
and Kenward [32] suggest starting from the MAR scenario and then adjusting the model
using MNAR assumptions in order to examine whether the MAR assumption is sensitive
to such changes.
A selection model, on the other hand, factors the joint distribution f (Y1i ,Y2i ,Ri )
differently; now the focus is on the mechanism behind the MNAR process:

f (Y1i ,Y2i ,Ri ) f ( Ri |Y1i ,Y2i ) f (Y1i ,Y2i ) . Numerous methods are based on this factorization; in
the third aim, a weighting approach is applied [36].

2.3.10 Resampling Methods (Aims 1 - 3)
Resampling methods were applied for several reasons:
1) Some methods, including Bayesian additive regression trees and random forest
could not be run in a reasonable amount of time on large datasets involving millions
of patients without resorting to a parallel computing environment. Instead, a
resampling approach was used to generate model performance estimates. For
example, in the first aim, 1000 smaller test and training datasets of 5000
observations each were generated by randomly sampling the full datasets with
replacement. Performance statistics were collected for each validation run and the
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overall mean and 95% confidence intervals generated by 1000 iterations were used
to compare the models’ relative performance.
2) In simulations, a resampling approach was used to generate large numbers of
independent training and validation datasets from actual VHA data rather than
relying on fully-generated data. This helped to ensure that the complex structures
and associations found in real patient observations were also present in synthetic
datasets. This was particularly important due to the complex correlation structure in
ICD-9 data. As demonstrated by Marshall et al. [37] and Gebregziabher et al. [38]
this approach is reasonable when the original dataset is large enough to help assure
independence between samples.

When applying resampling methods, steps were taken to ensure full
independence between training and validation datasets. In the first aim, training and
validation datasets were generated in pairs during each iteration, with steps taken to
ensure no observations were common to the two sets during the bootstrapping process.
In the second aim, 1000 training data sets were used to determine variable importance
measures, which were then used to determine the comorbidity score. The score, in turn,
was tested on 1000 validation data sets. Because the validation step took place after all
of the training datasets had been analyzed, it was necessary to randomly partition the
full dataset such that training data was drawn from one subset, and validation data from
the other. This ensured that validation data had not been used in model development.

17

2.4 Significance
This research made new contributions in the following areas:
1) Although other research has compared traditional statistical methods and machine
learning approaches in the development of predictive models for specific disease
conditions [39 – 44], to the best of the author’s knowledge, this is the first effort to
conduct a detailed application of such methods in the development of improved ICDbased disease burden models (aim 1) and an improved ICD-based summary score
(aim 2). In the first aim, the best models (Bayesian additive regression trees, random
forest, elastic-net and the pooled model) consistently had better predictive
performance when compared with the Elixhauser index. Similarly in the second aim,
the comorbidity summary score for predicting five-year mortality had stronger
predictive performance than the widely-used Elixhauser index.
2) This research provided a comprehensive comparison of multiple imputation methods
under both MAR and MNAR conditions, and in particular, developed new
applications for applying machine learning methods within the multiple imputation
with chained equations (MICE) framework. Additionally, several MNAR sensitivity
methods were adapted and applied, both in simulations and in actual data, to
demonstrate that unbiased inference may not be possible in some MNAR scenarios,
even when the missingness mechanism is fully understood. This result has direct
implications for VHA research involving missing race/ethnicity data.
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3. First manuscript: Comparison of Statistical and Machine Learning Methods for
Developing Improved Comorbidity Models Based on the ICD System

3.1 Introduction
When conducting healthcare outcomes research, accounting for disease burden
is essential for reducing the potential for bias in estimating the association between
outcomes and risk factors. For example, researchers designing studies to examine
disparities between racial and ethnic groups with diabetes must first account for each
patient’s other diseases and conditions; otherwise, the study is not likely to produce
meaningful results. Since this research frequently involves administrative healthcare
databases or electronic health records, this effort will become increasingly important as
the availability and quantity of such data continues to rapidly expand.
In administrative healthcare data, comorbidity information is found in numerous
forms, including physical exam notes, laboratory results and pharmacy records, but this
paper is concerned with that comorbidity information encoded by the International
Classification of Diseases, Clinical Modification (ICD-9-CM or ICD-10-CM), or by a
similar system. These variables consist of hierarchical codes. For example, in the ICD-9system, codes sharing the first three or first four digits are likely to involve related
diseases. This hierarchy creates a correlation structure, yet the methods commonly used
to model disease burden in ICD-CM data do not account for this structure. Nor do they
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attempt to account for any unidentified complex interactions and frequently do not
consider disease severity.
There are several well-known comorbidity summary indices based on the ICD
system. The Charlson Comorbidity Index [1] is a single score based on the sum of 17
weighted comorbidities. Deyo et al. [45], Romano et al. [8], Quan et al. [9] and others
developed closely related indices based on the same 17 comorbidities. In contrast to the
Charlson’s single summary score, Elixhauser et al. [2] developed a more complex index
that consisted of 31 distinct comorbidities. Because the outcome was in-hospital
mortality, Elixhauser excluded conditions related to the primary diagnosis, acute
complications related to treatment, or those considered unimportant. The Elixhauser
index was shown in several studies to be more effective than the Charlson Index for
predicting in-hospital mortality and one-year mortality and today remains one of the most
commonly used comorbidity indices based on the ICD system [2, 9,10]. Quan et al. [9]
developed enhanced indices that corrected inconsistencies in earlier algorithms and
added improved accounting for the ICD taxonomy, where the same condition might be
coded in several ways. Quan’s enhanced version of the ICD-9-CM Elixhauser index is
used as the basis for comparison here since it was shown to have superior predictive
performance over the earlier versions [9].
Kheirbek et al. [12] developed an ICD summary score called the multi-morbidity
index based on an application of the Naïve Bayes classification model. This index has
been applied in several large Veteran’s Administration populations to predict mortality
within 6 or 12 months [13]. The multi-morbidity index’s prediction performance was
shown to be superior against models based on the Quan variant of the Charlson index
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and the van Walraven variant of the Elixhauser index [11]. However, the authors only
considered the naïve Bayes approach, and did not demonstrate whether other statistical
or machine learning methods might produce superior results. Similarly, Siddique et al.
[46] relied on a single method (classification trees) to develop an ICD-9-CM based
algorithm for predicting which patients had lower gastrointestinal bleeding.
This work is based on the premise that advances in computing power, machine
learning and statistical methods since the Elixhauser Index’s introduction in 1998 will
support the development of improved ICD-based models with better predictive
performance. Seven statistical and machine learning methods for the analysis of high
dimensional data with binary ICD-CM predictors are compared. These methods apply
various approaches that were not considered in the Elixhauser index’s development,
including (1) empirically identifying latent features, (2) accounting for the inherent
hierarchical structure in ICD-CM data, (3) automatically incorporating complex
interactions, and (4) attempting to account for disease severity. Although other research
has compared traditional statistical methods and machine learning approaches in the
development of predictive models for specific disease conditions [39 – 44], to the best of
the author’s knowledge, this is the first effort to conduct a detailed comparison of such
methods in the development of an improved ICD-CM based comorbidity summary
measure.
This research is focused on the ICD-9-CM rather than the ICD-10-CM system
because it involves Veteran’s Administration data recorded under the ICD-9 system,
though the same methods could easily be applied to ICD-10-CM data.
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3.2 Study Design and Methods
This study was conducted in two phases. In the first phase, the seven methods
described below were applied, each in separate models for two populations. The
outcome was mortality within the study’s timeframe, and no ICD-9 codes were excluded
based on their temporal proximity to the patient’s death. Each model’s predictions were
compared to those from models based on the Elixhauser-Quan comorbidities derived
from the same ICD-9 data. Each model was trained using a single-disease population
and was validated using other patients drawn from the same population. In the second
phase, the top four models based on predictive performance from the first phase were
used to examine whether performance varied when the outcome was shifted to five-year
mortality instead of death within the study’s timeframe. Further, ICD-9 codes recorded
within one year of death were excluded since these might provide an unrealistic
advantage over the Elixhauser-Quan index. For example, the ICD-9 code for palliative
care is strongly associated with death but may not be useful for predicting mortality
several years in the future. Finally, in the second phase each model was again trained in
a single-disease population, but was now validated on a combined population equally
drawn from the traumatic brain injury and diabetes groups in order to examine how well
they each performed in a more general setting with a wider range of comorbidities.

3.2.1 Populations
Two national cohorts of U.S. Veterans were used; these had been created for
earlier studies by linking numerous Veterans Health Administration patient and
administrative databases. The first included 625,903 patients with diabetes mellitus (DM)
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based on two or more related ICD-9-CM codes and at least one prescription filled for a
medication to treat diabetes [47]. In the original study, Veterans were followed from 2002
until death, loss to follow-up, or until December 2006, and newer data was added to
extend the follow-time until December 2012. The second cohort involved 168,125
Veterans diagnosed with traumatic brain injury (TBI) during 2004 and 2005. In the
original study, patients were followed from the point of entry until death, loss to follow-up,
or until December 2010 [48]; newer data were added to extend the follow-time to
December 2014. Both studies were approved by the Medical University of South
Carolina Institutional Review Board (IRB) and the Ralph H. Johnson Veterans Affairs
Medical Center Research and Development committee.

3.2.2 Patient demographic and clinical covariates
Models termed ‘unadjusted’ used only on ICD-9 predictors; those termed
‘adjusted’ also controlled for each patient’s demographic and clinical covariates. In both
cohorts, the patient’s age in years was treated as a continuous variable. Race and
ethnicity were categorized as non-Hispanic white, non-Hispanic black, Hispanic, and
other / missing. Gender and marital status were treated as binary variables. In the TBI
cohort, homeless status was treated as a binary variable. TBI severity was categorized
as ‘not severe’, ‘moderately severe’, and ‘severe’. A binary variable was used to indicate
if the TBI injury was related to military service. The patient’s location was categorized
over the five Veterans Administration (VA) regions. The patient’s location by Rural Urban
Commuting Area (RUCA) code was categorized as ‘urban’, ‘rural’, and ‘highly rural’.
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Finally, the availability of poly-trauma treatment centers by VA station and by VA
integrated service network (VISN) were each included as binary variables.
Prior to analysis, erroneous duplicate formats of ICD-9 codes were identified and
corrected to the single correct format. For example, codes 250, 2500, and 25000 all
represent the same condition, but each would be treated as separate predictors in
machine learning algorithms. Next, the listing of unique ICD-9 codes gathered from all
patients was ranked by frequency. The 1000 most frequent codes formed the feature set
used in subsequent analyses, and this listing accounted for approximately 90% of all
ICD-9 codes recorded among all patients in the respective datasets.

3.2.3 Outcomes
In the first phase, the outcome was death within the study window; in the second
phase, the outcome was five-year mortality.

3.2.4 Methods
Each phase was conducted in two parts: (i) first prediction models were
developed using training datasets; (ii) each prediction model was then validated using
test data. Since computational efficiency was a concern for some methods due to the
very large datasets involved, resampling methods were used to generate 1000 smaller
test and training datasets of 5000 observations each by randomly sampling the full
datasets with replacement. Performance statistics were collected for each validation run,
and their mean and 95% confidence intervals were determined over 1000 iterations. As
demonstrated by Marshall et al. [37] and Gebregziabher et al. [49], this non-parametric
24

bootstrapping approach is reasonable for these large datasets, such that independence
between numerous samples is reasonably assured.

3.2.4.1 Generalized linear model with penalized maximum likelihood (elastic-net
regression):
Several penalized generalized linear models were considered, including ridge
regression [50], LASSO regression [51], elastic-net regression [52], and group LASSO
regression [53]. Elastic-net regression provided the best predictive performance in the
ICD-9-CM datasets. The elastic-net model incorporates both the LASSO and ridge
approaches with the addition of parameter  such that the loss function becomes the
LASSO model when  is 1, and the ridge model when  is 0. An iterative process
showed that  = 0.5 provided the best predictive performance. For binary outcome

y  (1,1) , predictors xi : (1, x1i ,..., xp 1,i ) and shrinkage parameter  , the following
equation was minimized in order to determine coefficient estimates [14]:
𝑚𝑎𝑥 𝑛
𝑝
𝑇
𝛽0 +𝛽 𝑇 𝑥𝑖
)} − 𝜆 ∑𝑗=1{𝛼|𝛽𝑗 | + (1 − 𝛼)𝛽𝑗2 }].
𝛽0 , 𝛽 [∑𝑖=1{𝑦𝑖 (𝛽0 + 𝛽 𝑥𝑖 ) − log(1 + 𝑒

The R package glmnet [54] was used to determine parameter estimates based on the
training data, and then used these estimates to generate predictions in the test data.

3.2.4.2 Model averaged regression coefficients (MARC):
This model is based on adapting a method developed by Glance et al. [55] for
their Trauma Mortality Prediction Model. This approach attempted to account for the
correlation structure created by the ICD-9-CM hierarchy. The first step involved creating
two generalized linear models using a probit link. The first model used the full ICD-9-CM
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code as it appears in the data. For the second model, Glance et al. relied on a separate
scale for trauma location and severity to group related injuries into higher level ‘bins’.
This would not be practical here since the models include every unique disease code
rather than a limited set of trauma injuries. Instead, each ICD code was collapsed to its
first three digits, thereby combining all information for a given hierarchy of related
comorbidities into a single high-level variable. The estimated coefficients for the two
models were then combined using an inverse variance weighting approach such that the
high-level model coefficients were weighted more when the variance of the
corresponding coefficient estimate was lower than that for the full model. Thus, when
there was little information about a particular comorbidity (and thus a higher estimated
coefficient variance), information from the related comorbidities in the hierarchy was
given a stronger weight.
The full model, which relied on the 5 digit ICD-9-CM code, was written:
1000


P  death   Φ   0   i xi  1age   2 gender   3rural   4 race   5 meds   6 marital  ,
i 1


th
where  is the probit link,  i and xi are the coefficient and binary indicator for the i

ICD-9-CM code, and

i

is the coefficient for a given patient covariate.

The high-level model, which collapsed data to the first three digits of the ICD-CM
code, was written:
J


P  death   Φ  0   j z j  1age   2 gender   3rural   4 race   5 meds   6 marital  ,
j 1
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where  j and z j are the j

th

coefficient and binary indicators for the J high level ICD-

CM variables created when the ICD-CM codes were collapsed to the highest level. The
parameter estimates from the two models were combined using weighted inverse
variances to produce a Model Averaged Regression Coefficient (MARC) for each of the
top 1000 ICD-CM predictors. That is,

MARCi 

1

1
var  ˆi 

ˆi 

1
1

var  ˆi  var ˆ j

 

 

var ˆ j

1
1

var  ˆi  var ˆ j

ˆ j ,

 

where var( ˆ j ) is a weighted variance of the ˆi ' s that map to a specific ˆ j , where each

ˆi ' s contribution to the overall variance was weighted by its inverse variance [55]:
var(ˆ j ) 

where Wi 

N

j
1
N j Wi [ˆi  E (ˆ )]2 ,

Nj  1 i 1

1
var(ˆi )
Nj

 var(ˆ )
k 1

Nj

and E (ˆ )  Wi ˆi .
i 1

k

Finally, new predictions were made using test data and the sum of each patient’s MARC
values associated with their ICD-9-CM codes. In summary, the MARC values were
determined from training data, and were then applied in test data for new patients in the
validation model:

P  death   Φ  C0  C1  MARCsum   1age   2 gender   3rural   4 race   5 meds   6 marital  .
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3.2.4.3 Naïve Bayes Variable Selection (multi-morbidity index)
Kheirbek et al. [12] developed an ICD summary score called the multi-morbidity
index based on an application of the Naïve Bayes classification model. For binary
random variables X = ( X1 ,

, X r ,... X d ) sampled from a population classified by two

categories ( i or j ), the odds of outcome i occurring are:

P (i | x)
P ( x | i ) P (i)

.
P( j | x) P( x | j ) P( j )
Each random variable is assumed to be independent of the others:
d

P(i | x)

P( j | x)

P(i ) P( xr | i )
r 1
d

P( j ) P( xr | j )

.

r 1

The posterior probability for outcome i can be easily calculated from the posterior odds
above. The assumption of independence among the predictors in X is questionable,
and Hand et al. [56] discuss reasons why this approach is nonetheless often successful.
In particular, the authors argue that although the Naïve Bayes approach may produce
biased estimates, the variance for such estimates is often lower than seen in less
parsimonious models. Further, for classification purposes such bias is not a hindrance
as long as it is in the right direction. Kheirbek et al. made several necessary
accommodations in order to apply the Naïve Bayes approach to ICD-9 data. For
perfectly separated predictors, the posterior odds were arbitrarily defined as 1 n  1
when all patients died and n  1 when all patients survived, where n is the number of
patients with a given ICD-9 code. Next, when the number of patients with a given ICD-9
code was small, data from related diagnoses in the same ICD-9 hierarchy were
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combined based on the assumption that related conditions have similar associations
with the outcome of interest.

3.2.4.4 Association Rules Analysis [14]:
This is an unsupervised machine learning method concerned with finding joint



values of predictors X 1, X 2, ... X p

 that appear most often in the data. Because ICD-9-

CM data is binary, the support for each X j is S  {0,1} , and the goal is to find
conjunctive rules based on regions in the X space with a larger probability for joint
occurrences:

Pr 


p
j1

(X j  s)  ,


where s is a single value of the support for X j . Next, the conjunctive rules are
transformed to become:

Pr 


p
kK

( Z k  1)   Pr  kK ( Z k  1)  ,


where Z k represents a binary dummy variable formed from one level of X j . The set of
predictors in conjunctive rule K is called the item set, and the number of Z k variables in
the set is known as the size. The estimated value for a conjunctive rule is called the
support or prevalence T :

T K  

1
N

N

 z
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ik

i 1 kK

,

where zik is the value of Z k for the i th observation. T thus represents the proportion of
observations which contain the conjunctive rule. When the item set K is divided into two
parts, such that antecedent A predicts the presence of consequent B , T ( K ) becomes

T ( A  B ) . The confidence C for this association could be viewed as finding P( B | A) :
C  A  B 

T  A  B
.
T  A

When the predictors which make up A appear in an observation, the confidence value
represents the probability that predictor B will also appear. Hastie et al. [14] comment
that association rules analysis is very good at finding combinations of variables that
appear frequently, but is less good at finding those with lower support. Thus we would
not expect to identify a joint occurrence that included at least one rare ICD-9-CM
diagnosis, even if this joint occurrence were strongly associated with the outcome.
The R package arules was used to implement association rules analysis [57].
Prevalence and confidence thresholds t and c were set to limit the number of rules
returned by the algorithm:

T ( A  B)  t and C ( A  B )  c .
Because this is an unsupervised method, joint occurrences were identified without
regard to the outcome of interest. Each candidate rule was tested for significance
against the outcome on a univariate basis using a different set of training data than that
used to generate the association rule. Multiple testing was accounted for during this
process using the Bonferroni adjustment, such that the critical value for significance
(p=0.05) was divided by the total number of rules that were tested. Next, LASSO
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regularized logistic regression was used to help determine which rules were most
important in predicting the outcome. The resulting association rules and their parameter
estimates were then used to make predictions for other patients in a test data set.

3.2.4.5 Random Forest (RF) [28]
This is a well-known ensemble method based on classification trees that relies
on bootstrap aggregation (or ‘bagging’) to generate a forest of generally uncorrelated
trees, where each tree then votes for the predicted outcome. The forest is termed
“random” due to the random selection of a pre-specified number of features (or predictor
variables) at each node; the feature that leads to the largest improvement in the tree’s
classification ability is then used to split the data at that node. The random forest method
can identify complex interactions, and was reported to be very competitive with other
machine learning methods when compared on the basis of misclassification error [14].
The R package randomForest was used to implement this method [58]. A forest was
generated using patients in a training dataset, which was then used to make predictions
on other patients in test data.

2.4.6 Bayesian Additive Regression Trees (BART) [59]
This is an extension of the supervised tree-based ensemble learning method,
but unlike random forest, prior distributions are established for each tree’s decision rules
and terminal node parameters, and an MCMC algorithm is used to sample from the
posterior distribution for the ensemble of trees. The authors contend their approach
provides a substantial degree of regularization such that each tree’s complexity is
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reduced. They also claim that the predictive results in some datasets were superior to
random forest, neural nets, and regularized regression methods [59]. For a BART model
with binary outcome Y , a probit model is used:

P[Y  1| x]  [G ( x)] ,
th
where x represents the data and G ( x ) is a summation of m trees, where the j tree is

designated as g ( x;Tj , M j ) :
m

G ( x)   g ( x; T j , M j ) .
j 1

Here, T and M are the tree’s decision rules and terminal node parameters, respectively,
and each is assumed to have independent and identical prior distributions. The prior for

T j is defined in multiple parts. First, the probability that a given node of depth d is nonterminal is  (1  d )



, for   (0,1),   [0, ) . Values of 0.95 and 2 were selected for

 and  , respectively in order to help limit each tree’s size. Finally, uniform priors were
used to model the splitting variable and splitting rule assignments for interior nodes in
each T j . For M j , a Gaussian prior distribution is assumed for the mean value

ij for

terminal node i within tree j:

ij ~ N (0,  2 ) , where    3.0 / k m ,
where m is the number of trees, typically 200, and k is a parameter typically set between
1 and 3. This prior serves to limit the values of G(x) to within (-3.0, 3.0), and thus shrinks
G(x) towards 0 and P(Y=1|x) towards 0.5.
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The R package BayesTree was used to implement BART [60]. This algorithm
develops the model based on the training data, and then provides the results of postconvergence samples from the posterior distribution using test data. The mean or
median of these samples is then used to provide a prediction for each test set
observation. The algorithm also returns the number of times each predictor is used in a
decision rule among all trees; this serves as a variable importance measure.

3.2.4.7 Pooled prediction model
An ensemble model was developed based on the combined predictions from all
of the models considered. Here each model’s test data predictions were used as
independent predictors in a logistic model using the same test data. The predictive
performance of this combined model was then compared against the other six models.

3.2.4.8 Elixhauser-Quan comparison model
Each of the above approaches was compared against a model based on the 31
independent Elixhauser-Quan comorbidities:




P  death   Φ  C 0 
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C (Elix _ comorb )   age   gender   rural   race   medcount   marital status  ,
i

i

1

2

3

4

5

6

i 1

where Ci is the estimated coefficient for the ith comorbidity from the enhanced
Elixhauser-Quan index [9].
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3.2.4.9 Model Performance Assessment
Area under the receiver operating characteristic curve (AUC), sensitivity,
specificity, positive predictive value (PPV) and negative predictive value (NPV) were all
considered when comparing models. Net reclassification improvement (NRI) was also
reported for events (patients who died) and non-events (patients who lived) [20]. While
NRI statistics have been widely adopted, Pepe et al. [21] showed they should be used
with caution. In particular, the authors demonstrated that positive NRI results could be
achieved in some situations where the new model involved an added variable with no
predictive value, possibly due to poorly fitting risk models. The AUC and related ROC
statistics provided reliable results in these situations. Primary emphasis was thus placed
on the AUC and related statistics; in particular, a strong positive NRI result was not
claimed as evidence for prediction performance improvement unless similar gains were
seen in the AUC. Finally, the Brier Score was reported as a measure of misclassification
error [22].

3.3. Results
Table 1 provides demographic information for the two populations examined in
this study and Figure 3 provides the percentage of each group diagnosed with each of
the 31 Elixhauser comorbidities. The DM cohort was older than the TBI group (mean age
73.1 versus 49.9), and had a higher five-year mortality rate (13.3% versus 4.4%). The
DM cohort had higher rates of congestive heart failure, peripheral vascular disorders,
hypertension, diabetes complications, and renal failure when compared to the TBI group.
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Table 1: Demographic characteristics for the Diabetes Mellitus (DM) and Traumatic Brain Injury
(TBI) cohorts
Traumatic
Diabetes
Variable
Level
Brain Injury
(n=625,903)
(n=168,125)
Five-year mortality (%)
Mean age
Gender (%)
Marital status (%)

Race/ethnicity (%)

Homeless (%)
Greater than 50% disability (%)

male
female
single
widowed
divorced
married
Non-Hispanic white
Non-Hispanic black
Hispanic
Other or missing
(service-connected)

13.3
73.1
97.0
3.0
7.0
11.0
21.0
59.0
76.0
15.0
5.0
4.0
8.0
27.0

4.4
49.9
93.7
6.3
26.0
4.6
25.9
42.1
55.8
13.0
1.9
29.2
1.5
23.3

The TBI cohort had substantially higher rates of depression, psychoses, drug abuse,
alcohol abuse, liver disease, and neurological disorders.
Table 2 provides a comparison of validation results for the DM and TBI cohorts
for the seven models that were compared against the Elixhauser-Quan model in phase
1, and Figures 4 and 5 provide a corresponding graphical comparison of confidence
intervals for each statistic based on 1000 iterations. Results labeled “unadjusted”
correspond to models in which only ICD-9-CM codes were used as predictors, while
“adjusted” models also included patient demographic variables. Overall, the BART,
random forest, elastic-net and pooled models had the best predictive performance as
seen in their consistently higher mean AUC values and lower Brier scores for unadjusted
and adjusted models in both cohorts. The MARC, association rules and multi-morbidity
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Figure 3: Prevalence of the 31 Elixhauser-Quan comorbidities in the diabetes and traumatic brain
injury cohorts

models were less successful when compared to the Elixhauser-Quan model, particularly
in the TBI population. In the TBI cohort, mean AUC values for unadjusted models varied
between 0.83 and 0.92, compared with 0.83 for the Elixhauser-Quan model. In the DM
cohort, they varied between 0.68 and 0.78, compared with 0.64 for Elixhauser-Quan
model. In general, net reclassification statistics for predicting mortality (NRI (event)) for
top-performing models were improved compared to the Elixhauser-Quan model, but NRI
(non-event) results were either similar or slightly worse, indicating an improved ability to
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Table 2: Mean performance statistics for Phase 1 models from validation data for the diabetes
and traumatic brain injury cohorts based on 1000 replications. Unadjusted models were based
only on ICD predictors, while adjusted models also included other patient demographic and
clinical variables. The outcome was death within the study timeframe.
Diabetes Mellitus Cohort (Phase 1 models)
ElixAssoc.
Naïve
Elastic- Random
MARC
BART
Pooled
Quan
Rules
Bayes
Net
Forest
unadj.

0.64

0.68

0.71

0.72

0.75

0.75

0.77

0.78

AUC

adj.

0.77

0.78

0.80

0.80

0.82

0.82

0.82

0.84

adj.

0.73

0.74

0.76

0.75

0.77

0.78

0.78

0.79

NRI
(event)

unadj.

ref

0.11

0.10

0.10

0.20

0.22

0.27

0.29

adj.

ref

0.04

0.07

0.03

0.09

0.12

0.12

0.14

ref

-0.05

-0.01

-0.02

-0.04

-0.05

-0.05

-0.05

ref

-0.02

-0.01

0.03

0.00

-0.01

0.00

0.01

0.23

0.22

0.21

0.21

0.20

0.20

0.19

0.19

unadj.
NRI
(nonevent) adj.

Brier Score

unadj.
adj.

0.19
0.18
0.17
0.18
0.17 0.17
0.16
0.16
Traumatic Brain Injury Cohort (Phase 1 models)
ElixAssoc.
Naïve
Elastic- Random
MARC
BART
Pooled
Quan
Rules
Bayes
Net
Forest

unadj.

0.83

0.83

0.83

0.87

0.92

0.91

0.91

0.92

adj.

0.87

0.89

0.88

0.88

0.92

0.92

0.91

0.93

NRI
(event)

unadj.

ref

0.14

0.06

0.20

0.22

0.27

0.24

0.27

adj.

ref

0.03

0.00

0.00

0.10

0.14

0.10

0.12

NRI
(nonevent)

unadj.

AUC

Brier Score

ref

-0.03

-0.02

-0.10

0.01

0.00

0.00

0.00

adj.

ref

0.00

-0.01

-0.02

0.01

0.00

0.01

0.01

unadj.

0.13

0.13

0.13

0.13

0.09

0.09

0.09

0.09

adj.

0.11

0.11

0.11

0.11

0.09

0.09

0.09

0.08

predict which patients would die, but no improvement for predicting which patients would
survive.
Table 3 and Figure 6 provide the results from phase 2, where the top-performing
methods in phase 1 were applied (BART, elastic-net, RF, and pooled models). Here the
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Figure 4: Diabetes Cohort performance statistics are shown for the unadjusted (in black) and
adjusted (in red) phase 1 models, with 95% confidence intervals based on 1000 iterations.
Adjusted models are based on both ICD code predictors and patient demographic variables,
while unadjusted models are based only on ICD code predictors. The outcome was death within
the study timeframe. NRI values for the Elix-Quan models are 0.00 since they serve as the
reference.

outcome was five-year mortality rather than death within the study’s timeframe, and ICD
codes recorded within one year of death were excluded in order to avoid favoring
conditions such as palliative care that would be strongly associated with death but would
provide little long term predictive ability. As in phase 1, each model was trained in a
single-disease dataset but was validated on a combined dataset comprised of the DM
and TBI groups. This permitted a better evaluation of predictive performance in a more
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Figure 5: Traumatic Brain Injury Cohort: performance statistics are shown for the unadjusted (in
black) and adjusted (in red) phase 1 models, with 95% confidence intervals based on 1000
iterations. Adjusted models are based on both ICD code predictors and patient demographic
variables, while unadjusted models are based only on ICD code predictors. The outcome was
death within the study timeframe. NRI values for the Elix-Quan models are 0.00 since they serve
as the reference.

general population with a wider range of comorbidities. Phase 2 included only ICD codes
as predictors since the phase 1 results demonstrated that adjusted for other covariates
did not provide additional predictive performance insights. The BART, RF, elastic-net
and pooled models were again superior to the Elixhauser model as seen in consistently
higher mean AUC values and lower Brier scores for unadjusted and adjusted models in
both cohorts. Similar to phase 1 results, the NRI statistics indicate performance gains
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Table 3: Mean performance statistics from validation data for phase 2 models for diabetes and
traumatic brain injury cohorts based on 1000 replications. Each model was trained on a singledisease dataset but was validated on a combined group drawn equally from the DM and TBI
datasets. All models were unadjusted, based only on ICD predictors. The outcome was five-year
mortality.
ElixhauserElastic- Random
BART
Quan
Net
Forest

Pooled

Diabetes cohort (training) with combined cohort (validation) (Phase 2)
AUC
NRI
(event)
NRI
(nonevent)
Brier Score

0.74

0.85

0.84

0.83

0.86

Ref

0.08

0.10

0.10

0.16

Ref

-0.01

-0.01

-0.01

-0.01

0.07

0.07

0.07

0.07

0.06

TBI cohort (training) with combined cohort (validation) (Phase 2 )
AUC
NRI
(event)
NRI
(nonevent)
Brier Score

0.74

0.89

0.88

0.83

0.89

Ref

0.27

0.23

0.20

0.29

Ref

-0.02

-0.02

-0.01

-0.02

0.07

0.06

0.06

0.06

0.06

were seen in predicting mortality but little improvement was seen in predicting survival.
In the TBI cohort, mean AUC values varied
between 0.83 and 0.89, compared with 0.74 for the Elixhauser-Quan model. In the DM
cohort, AUC values varied between 0.83 and 0.86, compared with 0.74 for ElixhauserQuan model. Table 4 provides a summary of comorbidities that were important
predictors of five-year mortality but which were not accounted for by the ElixhauserQuan index. These comorbidities were identified by finding the common group of ICD-9CM codes in the RF, elastic-net, and BART models for both the TBI and DM populations
40

Figure 6: Phase 2 model mean performance statistics are shown with 95% confidence intervals
based on 1000 iterations. Each model was trained on a single-disease dataset but was validated
on a combined group drawn equally from the DM and TBI datasets. All models were unadjusted,
based only on ICD predictors. The outcome was five-year mortality

which were not included in the Elixhauser index definition, were associated with mortality
rather than survival, and were ranked in the top 50% for variable importance by each
phase 2 model. Many of these conditions are related to functional status or cognitive
problems.
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Table 4: Summary of comorbidities from phase 2 models which were found to be important
predictors of five-year mortality but were not accounted for by the Elixhauser-Quan index. These
comorbidities were identified by finding the common group of ICD-9-CM codes associated with
mortality in the RF, elastic-net, and BART models for both the TBI and DM populations that were
consistently ranked in the top 50% for variable importance. This list was further narrowed to
include only those conditions not accounted for by the Elixhauser-Quan index. Many of the below
conditions are related to functional status or cognitive problems.
ICD-9-CM
code

Description

07051
29048
2948
3310
4111
41400

Acute hepatitis C
Vascular dementia
Other persistent mental disorders
Alzheimer's disease
Intermediate coronary disease
Coronary atherosclerosis of unspecified type of vessel

4293
436
43889
5234
5251
5939

Cardiomegaly
Acute but ill-defined cerebrovascular disease
Other late effects of cerebrovascular disease
Chronic periodontitis
Loss of teeth
Disorder of kidney and ureter, unspecified

600
7070
7809
7866
7872
7993

Hyperplasia of prostate
Pressure ulcer
Altered mental status
Swelling, mass, or lump in chest
Dysphagia
Debility, unspecified

V048
V604
V651
V670

Need for prophylactic vaccination against viral diseases
No other household member able to render care
Person consulting on behalf of another person
Follow-up examination following surgery
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3.4 Discussion
This work compared the performance of seven approaches for predicting patient
outcomes based on comorbidities derived from ICD-9-CM codes. To the best of the
author’s knowledge, this is the first effort to conduct a detailed comparison of statistical
and machine learning methods in the development of an improved prediction model
based on the ICD system. In the first phase, the outcome was death within the study’s
timeframe, and no ICD-9 codes in the patient’s record were excluded from consideration.
Models were validated with observations for other patients drawn from the same cohort.
The second phase involved a more robust evaluation of the top-performing models from
the first phase. The outcome was five-year mortality, ICD-9 codes recorded within one
year of death were excluded, and models were validated on a combined dataset drawn
from both disease populations.
In both phases, the BART, RF, elastic-net and pooled models consistently had
better predictive performance compared to models based on the Elixhauser-Quan index.
Each method may have succeeded due to different strengths, of which none were seen
in the Elixhauser-Quan approach. The pooled model, which attempted to merge the
strengths from individual models, appeared to offer the best results in both phases and
in both populations. This is consistent with conclusions that ensemble methods often
outperform any single classifier [19]. The elastic-net model provided a balanced
approach for handling possible collinearities between ICD-9 predictors while also
shrinking less important estimated coefficients towards zero. The successful machine
learning approaches (RF and BART) may automatically account for complex interactions
that might otherwise be overlooked by other methods. Additionally, most models
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attempted to account for a condition’s relative severity rather than considering each to
be an equally weighted and independent predictor.
Though the phase 2 models involved greater prediction challenges due to the
shift to five-year mortality, the exclusion of ICD-9 data within a year of death, and the
use of a wider population for validation, no substantial loss in predictive performance
was seen. Mean AUCs for unadjusted DM models improved in phase 2 by 6% to 10%,
while mean AUCs for unadjusted TBI models were 3% to 8% lower than for the
corresponding phase 1 model. In all cases, each model had substantially better
predictive performance when compared to the corresponding Elixhauser-Quan models.
This provides some evidence these methods could be generalized to a wider population
and to a range of different outcomes.
In addition to improved predictive performance, the phase 2 results provided
additional insights into the patient populations beyond those provided by the Elixhauser
index. As seen in Table 4, the patient’s functional status was an important predictor of
five-year mortality not accounted for by the Elixhauser-Quan model; examples of these
conditions include cognitive problems, pressure ulcers, and caregiver status. This
conclusion concerning functional status is consistent with previous research [61, 62].
Other serious conditions not included in the Elixhauser-Quan index were also identified;
examples include Alzheimer’s disease, cardiomegaly, and acute hepatitis C. These were
likely excluded from the Elixhauser Index because they were not highly associated with
the short-term outcomes used in its development.
Although the pooled model is based on a simple logistic regression, efforts to
develop more complex ensemble models with improved prediction performance did not
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lead to any improvements. For example, the prediction densities from the BART, RF
and elastic net models were plotted separately for true positive, false positive, true
negative and false negative training data observations under the pooled model.
Differences in respective densities between the four groups were used to adjust the
pooled model predictions, but this led to a slight drop in predictive performance. For
example, any prediction improvement in the false negative group was negated by a
decline in the true negative group.
There are several important limitations. First, this work was limited to two
populations of generally older, male Veterans, and it was not demonstrated whether
these methods would achieve similar results in other groups. Next, the use of
administrative data imposes substantial risks for measurement inaccuracies and missing
data. For example, one patient might have different ICD-9-CM codes entered for the
same condition. In some cases less severe comorbidities such as diabetes, depression,
angina or high blood pressure may be omitted from the record for critically ill patients; as
a result, these conditions have been incorrectly associated with lower mortality odds in
some studies [2]. Additionally, patients with good functional status and access to
healthcare are more likely to have detailed health information recorded, while patients
who are housebound, live in isolated rural areas, have cultural obstacles, or are
otherwise disadvantaged are more likely to have incomplete records. Despite these
sources of potential bias, a large body of previous work has shown that meaningful
inference is possible from these data.
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4. Second Manuscript: Improved Comorbidity Summary Score for Measuring Disease
Burden and Predicting Outcomes with Applications to Three National Cohorts
4.1. Introduction
Research involving administrative healthcare data to study patient outcomes
requires the investigator to carefully consider the patient’s comorbidities, or disease
burden in order to reduce the potential for biased inferences. This paper focuses on
developing an improved summary score using one of the most popular sources for
comorbidity information, that encoded by the International Classification of Diseases
(ICD), which, in the ICD-9-CM version, consists of more than 14,000 unique codes. Each
patient may have hundreds of ICD codes recorded over many years, and a large
database may contain thousands of unique codes. Summary measures based on
dimension reduction have thus become very popular tools. In some cases, these
measures consist of a collection of disease conditions that serve as independent
predictors; the Elixhauser comorbidity index is perhaps the most well-known example
[2]. Other measures consist of single scores, such as the Charlson comorbidity index
[1]. Because the Charlson and Elixhauser indices are well known and have been widely
applied, investigators frequently use them without consideration for whether other
methods could better adjust for disease burden.
ICD codes are primarily recorded for billing purposes, which can introduce
numerous challenges when they are applied in research. Some disease conditions are
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found to be under-reported when ICD codes are compared to the patient’s clinical record
[1, 63, 64]. Further, some chronic conditions such as high blood pressure or obesity are
more likely to be recorded for patients who are generally fit, but more likely to be omitted
for patients who are critically ill. Investigators have shown how this can lead to the false
conclusion that some chronic conditions are associated with lower mortality odds [2].
This observation supported a hypothesis examined in this paper that gains in ICD
summary measure performance might be made by including codes in prediction models
that are associated with survival even when the clinical evidence suggests such codes
may actually be associated with mortality.
The Charlson and Elixhauser indices were developed by different approaches,
and were initially used to predict different outcomes. Charlson et al. [1] collected the
comorbidities observed in 607 patients with hospital admissions during one month in
1984; these patients were then followed for one year. She used those baseline
comorbidities to predict time to death over the one year period using Cox proportional
hazards models. The relative magnitudes of the estimated coefficients were used to
develop a weighted score that was validated in a population of 685 breast cancer
patients. Elixhauser later noted that the Charlson score was soon repurposed by other
investigators to predict numerous events other than one-year mortality, including shortterm outcomes such as in-hospital mortality, hospital charges or length of stay. She was
also concerned that the range of Charlson comorbidities was limited by the small
population used to develop the score. Elixhauser et al. [2] instead considered the full
range of conditions included in the ICD-9-CM coding manual as well as the comorbidities
considered in a number of current studies. Her models were limited to predicting short47

term hospitalization outcomes, and used a narrow comorbidity definition that excluded
conditions related to the primary reason for hospitalization, problems that might be
complications that arose during treatment, or conditions she considered unimportant. To
assess which conditions were most predictive, she conducted ordinary least squares
regression or logistic regression to predict hospitalization charges, length of stay, or inhospital mortality. She proposed an index of 31 independent comorbidities, and
deliberately avoided combining them into a single score because she considered each
investigator should examine the independent contributions of comorbidities where
possible. Her index did not include numerous serious conditions that were not strongly
associated with her short-term hospitalization outcomes; examples include dementia,
Alzheimer’s disease, or some types of renal disease. She reported that by excluding any
condition that could be considered a complication of treatment, her index was less
successful in predicting mortality than her other short-term outcomes. Such excluded
conditions included pneumonia, cardiac arrest, cardiogenic shock, and respiratory failure
[2].
The Elixhauser index has subsequently been applied to a wide range of
outcomes, in some cases with little apparent regard for the reasoning behind the index’s
construction. For example, Baldwin et al. [65] used the Elixhauser index in models to
predict two-year non-cancer mortality and the receipt of chemotherapy in cancer
patients; Chu et al. [10] used it to predict one-year mortality; Lix et al. [66] used it to
predict amputation, end stage renal disease, and stroke in diabetes patients. Since the
Elixhauser index deliberately omitted numerous conditions not strongly associated with
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short-term hospitalization outcomes or associated with treatment complications, the
index may be less effective in predicting these other outcomes.
Both the Charlson and Elixhauser indices were developed using simple
regression and proportional hazards models, and both involved arbitrary inclusion or
exclusion of specific conditions rather than relying on strictly empirical methods to
determine which predictors were most important. Since their development, numerous
advances in statistical methods, machine learning algorithms, and computational power
have occurred. In the first manuscript, a number of machine learning and statistical
classification methods were compared to demonstrate that substantial improvements in
prediction performance over existing indices could be achieved to predict five-year
mortality. The most effective of these methods included Bayesian Additive Regression
Trees (BART), Random Forest (RF), and elastic-net penalized generalized linear
models. However, such models included up to 1000 predictors and could be
cumbersome to apply in some areas of research. Here the goal is to instead develop a
simple comorbidity summary score based on the insights gained in the previous work
and show it has superior predictive performance to the Quan version of the Elixhauser
index [9] when used to predict five-year mortality. The Elixhauser index is used as the
basis for comparison because it was shown to have better predictive performance than
the Charlson Index; the Quan version is used because of its improved performance over
earlier versions of the Elixhauser Index [9]. The ICD-9-CM is included here rather than
the ICD-10-CM system because the Veteran’s Administration data used here was
recorded under the older ICD-9 system, though the same methods could easily be
applied to ICD-10-CM data.
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4.2. Study Design and Methods
4.2.1 Study Populations
Three national cohorts of U.S. Veterans were used in this work; these had been
created for earlier studies by linking numerous Veterans Health Administration patient
and administrative databases. The first included 625,903 patients with diabetes mellitus
(DM) based on two or more related ICD-9-CM codes and at least one prescription filled
for a medication to treat diabetes [47]. In the original study, Veterans were followed from
2002 until death, loss to follow-up, or until December 2006, and newer data was added
here to extend the follow-time until December 2012. The second cohort involved
168,125 Veterans diagnosed with traumatic brain injury (TBI) during 2004 and 2005. In
the original study, patients were followed from the point of entry until death, loss to
follow-up, or until December 2010 [48]; newer data was added to extend the follow-time
to December 2012. The third cohort involved 3,359,560 patients with chronic kidney
disease (CKD) defined for stages 1 through 5 based on estimated glomerular filtration
rates calculated from serum creatinine levels and the patient’s age, gender, and race.
CKD patients were also identified through ICD-9-CM codes. CKD patients were followed
from 2000 until December 2012, loss to follow-up, or until death. Kidney or liver
transplant recipients were excluded (M. N. Ozieh, M. Gebregziabher, R. Ward, D. J.
Taber, L. Egede, unpublished data, 2016). All studies were approved by the Medical
University of South Carolina Institutional Review Board (IRB) and the Ralph H. Johnson
Veterans Affairs Medical Center Research and Development committee.
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4.2.2 Covariates and outcome
The predictors in all models were binary variables, each based on a single ICD
condition. No other predictors were included since it was demonstrated in the first
manuscript that no additional insights into effective modeling of ICD data were obtained
by including other patient covariates. The outcome for all models was five-year mortality.

4.2.3 Methods
Figure 7 provides an overview of the index development steps. For each patient
in the three disease cohorts, the available ICD-9-CM codes were collected from the
earliest available data until one year prior to mortality or through the end of the study if
the patient did not die. Codes recorded within a year of death were excluded because
conditions that often occur in this period (such as palliative care) might provide an
unrealistic advantage against the Elixhauser models but would provide little help in
making long-term predictions. An early cutoff for starting ICD collection was not
established; instead all available codes were used for each patient. The challenge for
the competing models was similar to asking, “given all of the patient’s ICD codes up until
today, predict whether he or she will die in the next five years.” Although patients varied
by the length of available ICD code history, this was considered this was an expected
condition in chronic disease cohorts, and results were compared to those from
Elixhauser models that faced the same challenges.
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Figure 7: Overview of summary score development.

Prior to analysis, erroneous duplicate formats of ICD-9 codes were identified and
corrected to the single correct format. For example, codes 250, 2500, and 25000 all
represent the same condition, but each would be treated as separate predictors in
machine learning algorithms. Out of the approximately 14,000 unique ICD-9 codes, the
1000 most prevalent codes for each cohort were retained, and then those codes that
were not common to all cohorts were excluded. There were 814 such codes, which
formed the common set of binary predictors, where a ‘1’ indicated the given ICD-9-CM
code was found in a patient’s record.
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Four types of training and validation data sets were generated; three were drawn
from the DM, CKD and TBI cohorts, and the fourth was a combined cohort created by
sampling in approximately equal proportions from the three disease cohorts. Use of the
combined cohort was intended to show how well the index might function in a more
general population.
Resampling methods were used due to concerns for computational efficiency
with the machine learning methods, for which is could be difficult or impossible to
complete an analysis of the entire dataset without use of a parallel computing
environment. Smaller test and training datasets were generated, each with 5000
observations, by randomly sampling the full datasets 1000 times with replacement.
Performance statistics were collected for each validation run and the overall mean and
95% confidence intervals generated by 1000 iterations were used to compare the
models’ relative performance. As demonstrated by Marshall et al. [37] and
Gebregziabher et al. [49], this non-parametric bootstrapping approach is reasonable for
our large datasets, such that independence between numerous samples is reasonably
assured.
4.2.3.1 Prediction Models
The top-performing methods from the first manuscript: random forest (RF),
Bayesian additive regression trees (BART) and elastic-net penalized regression (REG),
are again used here to provide variable importance measures for use in summary score
development. The machine learning methods (RF and BART) are capable of
automatically accounting for complex interactions between predictors that are likely to
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exist in these data. Elastic-net penalized regression provides an efficient way to handle
possible collinearities between predictors, while shrinking the estimated coefficients of
less important predictors. Each method is used to develop separate estimates of
variable importance for use in index development.
Random forest [28] is an ensemble method based on classification trees that is
often effective in datasets with many weak predictors, as is the case with ICD-9 data. It
relies on bootstrap aggregation (or ‘bagging’) to generate a forest, which is termed
“random” due to the random selection of a pre-specified number of features (or predictor
variables) at each tree’s nodes. The feature that leads to the largest improvement in the
tree’s classification ability is then used to split the data at that node. The random forest
method can automatically account for complex interactions, and was reported to be very
competitive with other machine learning methods when compared on the basis of
misclassification error [14]. Each variable’s mean decrease in the Gini Index is used as a
measure of variable importance for use in model development. For N m observations at
node m, for outcome variable y with class levels k, and with predictors x  Rm , the
proportion of observations at a node for a given predictor and class level k is

pˆ mk 

1
Nm

 I(y  k ) .

xi Rm

i

The Gini Index at this node is given by [14] :
K

G   pˆ mk (1  pˆ mk ) .
k 1

Large changes in the Gini index at a given node indicate the splitting variable’s
importance is relatively high, and the mean decrease over all nodes involving a given
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predictor across all trees and across 1000 iterations is used as the variable importance
measure. These values are always positive, regardless of whether a predictor is
associated with survival or mortality. The R package randomForest is used to implement
this method [58] .
Bayesian Additive Regression Trees (BART) [60] is an extension of the
supervised tree-based ensemble learning method, but unlike random forest, prior
distributions are established for each tree’s decision rules and terminal node
parameters, and an MCMC algorithm is used to sample from the posterior distribution for
the ensemble of trees. The authors contend their approach provides a substantial
degree of regularization such that each tree’s complexity is reduced. Predictive results
reported in some datasets were superior to random forest, neural nets, and regularized
regression methods [60].
The R package BayesTree was used to implement BART [59]. This algorithm
develops the model based on the training data, and then provides the results of postconvergence samples from the posterior distribution using test data. Variable importance
is estimated by the mean count of how many times each predictor is selected for use in
a node’s decision rule among all trees over all MCMC samples and over all 1000
iterations. These values are always positive.
Elastic-net regression, which involves the use of a regularized generalized linear
model, provided another measure of variable importance. In the work supporting the first
manuscript a number of regularized regression methods were compared, including ridge
regression [50], LASSO regression [51], elastic-net regression [52], and group LASSO
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regression [53], and found that elastic-net regression provided the best predictive
performance in the ICD code data. The elastic-net model combines the LASSO and
ridge approaches with the addition of parameter  such that the loss function becomes
the LASSO model for   1 , and the ridge model when   0 . For binary outcome

y  (1,1) , predictors xi : (1, x1i ,..., xp 1,i ) and shrinkage parameter  , the following
equation is minimized in order to determine coefficient estimates:

 n

 yi   k xik
p
 min   log(1  e k 1 )    j 1{  j  (1   )  j2 } .
 i 1



p

 = 0.5 provided the best predictive performance. The R package glmnet [54] was used
to implement this method, and used the mean coefficient estimates from 1000 iterations
as variable importance measures. The sign of the mean coefficient estimates were used
to weight the index by 1 based on the association with survival or mortality, as
discussed further below.
4.2.3.2 Score algorithm:
When analyses were completed on the DM, TBI, CKD and combined datasets,
there were 12 variable importance results from the RF, BART and REG models for each
of the 814 ICD-9-CM predictors. The following algorithm was used to develop a
summary score:
(1) Determine which predictors have variable importance measures ranked in the
top 50% in all 12 results.
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th
(2) For p such predictors and the i patient, establish dij : di1 ,di 2 ,...,d ip ,

d  (0,1) , to signify which predictors are recorded in a given patient’s record.
(2) Determine whether each predictor is associated with mortality or survival
based on whether the majority of elastic-net estimated parameters from the four
datasets are positive or negative; in the rare case of a tie assume a mortality
association. Note that RF and BART variable importance measures are always positive
regardless of the association.
(3) Assign weights w :{w1 , w2 ,..., wp } of +1 to those conditions associated with
mortality and -1 to those associated with survival.
p

(4) Calculate a summary score for each patient: Si

w j d ij .
j 1

4.2.4.3 Score assessment
The summary score was used as the single predictor in a logistic regression
models using validation datasets from each of the four population groups. Its
performance was compared to similar models based on the Elixhauser index using the
area under the ROC curve (AUC), net reclassification improvement, Brier score [22],
sensitivity and specificity statistics.
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Table 5: Demographic information for the Chronic Kidney Disease, Diabetes and Traumatic Brain
Injury cohorts.

Variable
Mean age
Five-year mortality (%)
Gender (%)
Marital status (%)

Race/ethnicity (%)

Homeless (%)
Greater than 50%
disability (%)

Chronic
Traumatic
Kidney Diabetes
Brain
Disease
Injury

Level

male
female
single
widowed
divorced
married
Non-Hispanic white
Non-Hispanic black
Hispanic
other or missing

service-related

75.0
41.9
96.7
3.3
6.3
14.8
21.0
58.0
81.4
13.6
2.9
2.2
6.3

73.1
38.7
97.0
3.0
7.0
11.0
21.0
59.0
76.0
15.0
5.0
4.0
8.0

49.9
20.9
93.7
6.3
26.0
4.6
25.9
42.1
55.8
13.0
1.9
29.2
1.5

23.4

27.0

23.3

4.3. Results
Table 5 provides a summary of demographic information for the three cohorts.
Five-year mortality ranged between 20.9 and 41.9%. The TBI cohort’s mean age was
49.9, while the other groups had mean ages of 75.0 and 73.1. The groups’ gender and
racial-ethnic makeup is typical for Veteran populations with these age distributions.
Between 23% and 27% of Veterans had at least 50% disability connected with their
military service.
Figure 8 and Table 6 compare the performance of the summary score to the
Elixhauser index based on area under ROC curve (AUC), Brier score, net
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Figure 8: Mean performance statistics with 95% confidence intervals based on 1000 iterations
using validation datasets for the chronic kidney disease (CKD), traumatic brain injury (TBI), type 2
diabetes mellitus (DM), and the combined cohort, which was formed by randomly drawing from
the first three cohorts in equal proportions. AUC is the area under the receiver operator
characteristic curve; NRI (event) and NRI (nonevent) are the net reclassification improvement
statistics for mortality and survival. NRI values for the Elixhauser models are set at 0.00 since
they serve as the reference. The outcome was five-year mortality. In each cohort, summary score
models demonstrated significantly better predictive performance compared to models based on
the 31 Elixhauser comorbidities.

reclassification improvement, sensitivity, and specification statistics from models
validated on each disease cohort and on a combined cohort. Mean AUC values for the
four datasets ranged between 0.81-0.84 for the new score, and between 0.72 - 0.78 for
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Table 6: Mean performance statistics with 95% confidence intervals based on 1000 iterations
using validation datasets for the chronic kidney disease (CKD), traumatic brain injury (TBI), type 2
diabetes mellitus (DM), and the combined cohort, which was formed by randomly drawing from
the first three cohorts in equal proportions. AUC is the area under the receiver operator
characteristic curve; NRI (event) and NRI (nonevent) are the net reclassification improvement
statistics for mortality and survival. NRI values for the Elixhauser models are set at 0.00 since
they serve as the reference. The outcome was five-year mortality. In each cohort, summary score
models demonstrated significantly better predictive performance compared to models based on
the 31 Elixhauser comorbidities.
Cohort
CKD
TBI
Summary
Summary
Index
Elix-Quan
Elix-Quan
Score
Score
AUC
Sensitivity
Specificity
NR(event)
NRI(nonevent)
Brier Score

0.72 (0.70;
0.46 (0.42;
0.82 (0.80;
ref
ref
0.21 (0.20;

0.73)
0.50)
0.84)

0.21)

Cohort
Index
AUC
Sensitivity
Specificity
NR(event)
NRI(nonevent)
Brier Score

0.81 (0.80; 0.82)
0.66 (0.64; 0.68)
0.81 (0.79; 0.82)
0.20 (0.16; 0.24)
-0.02 (-0.04; 0.01)
0.17 (0.17; 0.18)

0.78 (0.77;
0.24 (0.20;
0.96 (0.95;
ref
ref
0.14 (0.13;

0.80)
0.29)
0.96)

0.14)

DM
Elix-Quan
0.72 (0.71;
0.41 (0.36;
0.86 (0.84;
ref
ref
0.20 (0.20;

0.74)
0.45)
0.89)

0.21)

0.84 (0.83;
0.39 (0.35;
0.97 (0.95;
0.15 (0.10;
0.01 (0.00;
0.11 (0.11;

0.85)
0.49)
0.97)
0.24)
0.02)
0.12)

Combined
Summary
Score

0.84 (0.83; 0.85)
0.69 (0.61; 0.71)
0.83 (0.82; 0.86)
0.28 (0.22; 0.33)
-0.03 (-0.06; 0.00)
0.16 (0.15; 0.16)

Elix-Quan
0.74 (0.73;
0.36 (0.32;
0.89 (0.88;
ref
ref
0.19 (0.18;

0.75)
0.40)
0.91)

0.19)

Summary
Score
0.84 (0.82; 0.85)
0.60 (0.51; 0.64)
0.88 (0.86; 0.92)
0.24 (0.15; 0.29)
-0.01 (-0.03; 0.02)
0.15 (0.15; 0.16)

the Elixhauser index. Brier score values were consistent with the AUC results. Mean
sensitivity values for the new score ranged between 0.39 – 0.69, compared to 0.24 –
0.46 for the Elixhauser index. Mean specificity values for the score ranged between 0.81
– 0.97, compared to 0.82 – 0.96 for the Elixhauser models. Mean net reclassification
improvement (NRI) statistics for predicting mortality or survival were consistent with the
respective trends in sensitivity and specificity.
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Table 7 (following the Discussion section) lists the ICD-9-CM codes used to
predict five-year mortality in the summary score, and indicates whether each code is
included in the Elixhauser index’s definition. Overall, 97 of the 121 codes in the index
were not part of the Elixhauser index definition, and 63 of the 121 codes are associated
with mortality.

4.4. Discussion
This work produced a comorbidity summary score for predicting five-year
mortality that had stronger predictive performance than the widely-used Elixhauser
index. The models used in the score’s development were trained and validated on three
large Veterans Administration datasets and further validation was based on a combined
cohort, which provided a broad range of comorbidities and disease severity levels. The
score was comprised of ICD-9 codes with variable importance measures that fell in the
top 50% of all twelve model runs (four training datasets and three classification
methods). Strong improvements in predictive performance were demonstrated based on
AUC and Brier Score statistics. There were also some improvements in sensitivity and
net reclassification improvement for mortality when compared to the Elixhauser index,
while specificity values remained generally the same. The score’s strong performance in
the combined cohort provided some initial evidence that it could be successfully applied
to a more general population, but further work is needed to demonstrate this.
The summary score approach differs from existing measures in several ways:
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(1) First, 58 of 121 conditions were negatively weighted since they were
associated with survival in the models, and many patients had an overall negative score.
As hypothesized, by including codes statistically associated with survival, model
predictive performance improved, even when the clinical evidence suggests such codes
in some cases may actually be associated with mortality. Such codes may be recorded
in healthier patients who are not being treated for more serious conditions (obesity or
hyperlipidemia for example); other codes in this category simply recorded routine
outpatient visits (routine screening or exam codes). The models predicted that patients
with large numbers of these negatively weighted conditions and few of the more serious
illnesses are more likely to survive.
(2) Next, the summary score is simpler to implement since it consists of only 121
ICD-9 codes, compared to more than 1000 unique codes in the Elixhauser index
definition.
(3) While the Elixhauser index definition excluded conditions not associated with
short-term hospitalization outcomes and any acute conditions considered treatment
complications, all such conditions that occurred at least one year prior to death were
considered since they could be valid mortality predictors. This approach is more suitable
for the long-term outcome was considered here. Examples of acute conditions included
in the summary score but excluded in the Elixhauser index include pneumonia and acute
cerebrovascular disease.
(4) The summary score contained a number of conditions related to the patient’s
functional status that were not covered by the Elixhauser index, including Alzheimer’s
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disease, senile dementia, hearing loss, persistent mental disorders, memory loss, falls,
no other household member able to render care, and urinary incontinence.
Several conditions in the summary score may have unexpected associations with
mortality, and warrant further discussion. For example, nail dermatophytosis, or nail
fungal infection, might generally be considered a benign condition, but Scher et al. [67]
and Loo [68] report its prevalence rises both with age and the presence of peripheral
vascular disease and diabetes. This may explain its predictive importance in these
Veteran populations. In another example, the code ‘V048: need for prophylactic
vaccination against other viral diseases’ might also be considered to be benign, but
further investigation showed this code may be a proxy for age since its use was
discontinued in 2003 when it was replaced by a number of other codes [69].
The new comorbidity measure is not intended to provide a comprehensive
clinical summary of a patient’s disease burden; instead, it provides a simple prediction of
five-year mortality based on a comparison with millions of other Veterans for whether a
the patient has specific conditions that were most predictive in this population.
Although summary scores are convenient tools, investigators should apply them
with care. As Elixhauser et al. noted [2], combining individual predictors into a single
index may lead to a loss of explanatory power. Romano et al. [8] commented that
summary indices might be most appropriate in small datasets where it is not feasible to
model a large group of comorbidities. They also warned that investigators should not
apply an index without carefully considering the assumptions and outcomes used in its
development; this is a warning that appears to be unheeded by many investigators.
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Scneeweiss et al. [70] further cautioned that the weights developed for one population
are not likely to be generalizable to other groups. Although the new score was
developed using three large datasets involving different disease cohorts with a wide
variety of comorbidities, these populations are generally limited to older male Veterans,
and further work is needed to determine the score’s predictive performance in a wider
population. As Scneewiess et al. [70] wrote, a summary score might be most suitable for
use as a convenient data exploration tool to rapidly assess large ICD code datasets. In
general, investigators working with such data may be most successful by developing
dedicated comorbidity models for their unique populations and outcomes using the
methods described here.
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Table 7: ICD-9-CM conditions that form the summary score, ordered by ICD hierarchy. Those
conditions contained in the Elixhauser index definition [9] are indicated by a “+” symbol.
Conditions associated with mortality have an index weight of +1; those associated with survival
have weights of -1. 97 of the 121 codes in the index were not part of the Elixhauser index
definition, and 63 of the 121 codes are associated with mortality. Many of those conditions not
included in the Elixhauser index definition are related to the patient’s functional status.
Contained
in
Elixhauser
Definition
+

+
+
+
+

+
+
+
+
+
+

+

+

Index
Weight

ICD-9CM
code

Condition

1
1
1
1
1
1
1
1
-1
-1
1
1
-1
1
1
1
1
1
1
1
-1
-1
1
1
-1
-1
1
1
1
-1
1

1101
1629
1733
1739
185
25000
25001
25060
2722
2724
2765
2767
27800
2809
2859
2875
2900
2948
2949
2989
30272
32723
3310
3320
33829
3540
36201
36250
36251
36501
36610

Dermatophytosis of nail
Malignant neoplasm of bronchus and lung, unspecified
Unspecified malignant neoplasm of skin, unspecified parts of face
Other malignant neoplasm of skin
Malignant neoplasm of prostate
Diabetes mellitus without mention of complication
Type I Diabetes mellitus
Diabetes with neurological manifestations
Mixed hyperlipidemia
Other and unspecified hyperlipidemia
Volume depletion disorder
Hyperpotassemia
Obesity, unspecified
Iron deficiency anemia, unspecified
Anemia, unspecified
Thrombocytopenia, unspecified
Senile dementia, uncomplicated
Other persistent mental disorders
Unspecified persistent mental disorders
Unspecified psychosis
Psychosexual dysfunction
Obstructive sleep apnea
Alzheimer's disease
Parkinson’s disease
Other chronic pain
Carpal tunnel syndrome
Background diabetic retinopathy
Macular degeneration (senile), unspecified
Nonexudative senile macular degeneration
Open angle glaucoma with borderline findings, low risk
Senile cataract, unspecified
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Table 7 (continued)
Contained
in
Elixhauser
Definition

+
+
+
+

+

+
+
+
+

+
+

Index
Weight
-1
-1
-1
1
1
1
1
1
1
1
1
1
1
1
1
-1
-1
-1
-1
-1
1
1
1
-1
1
1
-1
-1
1
1
1
-1
1
1
1
1
-1
-1
-1
-1
-1

ICD9CM
code
3671
38830
38831
38910
3892
40391
41400
4241
42731
4280
436
4389
4439
4538
45981
4619
462
4659
4739
4779
486
49121
4928
49390
496
51889
52102
52103
5715
5789
585
5920
5939
5990
5997
7051
71536
71941
71944
71946
71947

Condition
Myopia
Tinnitus, unspecified
Subjective tinnitus
Sensorineural hearing loss, unspecified
Mixed conductive and sensorineural hearing loss
Hypertensive chronic kidney disease with end stage renal disease
Coronary atherosclerosis
Aortic valve disorders
Atrial fibrillation
Congestive heart failure, unspecified
Acute, but ill-defined, cerebrovascular disease
Unspecified late effects of cerebrovascular disease
Peripheral vascular disease, unspecified
Acute venous embolism and thrombosis of other specified veins
Venous (peripheral) insufficiency, unspecified
Acute sinusitis, unspecified
Acute pharyngitis
Acute upper respiratory infections of unspecified site
Unspecified sinusitis (chronic)
Allergic rhinitis, cause unspecified
Pneumonia, organism unspecified
Obstructive chronic bronchitis with (acute) exacerbation
Other emphysema
Asthma, unspecified type, unspecified
Chronic airway obstruction
Other diseases of lung, not elsewhere classified
Dental caries extending into dentine
Dental caries extending into pulp
Cirrhosis of liver without mention of alcohol
Hemorrhage of gastrointestinal tract, unspecified
Chronic kidney disease
Calculus of kidney
Unspecified disorder of kidney and ureter
Urinary tract infection
Hematuria
Acute hepatitis C without mention of hepatic coma
Osteoarthrosis, localized, lower leg
Pain in joint, shoulder region
Pain in joint, hand
Pain in joint, lower leg
Pain in joint, ankle and foot

66

Table 7 (continued)
Contained
in
Elixhauser
Definition

Index
Weight

ICD-9CM
code

-1
-1
-1
-1
-1
1
-1
1
1
-1
1
1
-1
-1
1
1
-1
-1

7231
7242
7243
72690
72871
73300
78057
78097
7812
7820
7823
78321
7840
78659
78820
78830
79021
79029

1

7931

-1
1
-1
1
-1
1

7962
7993
9953
E8889
V0382
V048

-1
-1
-1
1
-1
1
1
-1
1
-1
-1
-1
-1

V0481
V065
V1272
V431
V531
V583
V5861
V5883
V604
V653
V6540
V6549
V659

Condition
Cervicalgia
Lumbago
Sciatica
Enthesopathy of unspecified site
Plantar fascial fibromatosis
Osteoporosis, unspecified
Unspecified sleep apnea
Altered mental status
Abnormality of gait
Disturbance of skin sensation
Edema
Loss of weight
Headache
Other chest pain
Retention of urine, unspecified
Urinary incontinence, unspecified
Impaired fasting glucose
Other abnormal glucose
Abnormal findings on radiological /other examination of lung
field
Elevated blood pressure reading without diagnosis of
hypertension
Debility, unspecified
Allergy, unspecified, not elsewhere classified
Unspecified fall
Other vaccinations against streptococcus pneumoniae
Need for prophylactic vaccination, other viral diseases
Need for prophylactic vaccination and inoculation against
influenza
Need for prophylactic vaccination against tetanus-diphtheria
Personal history of colonic polyps
Lens replaced by other means
Fitting and adjustment of spectacles and contact lenses
Attention to dressings and sutures
Long-term (current) use of anticoagulants
Encounter for therapeutic drug monitoring
No other household member able to render care
Dietary surveillance and counseling
Counseling NOS
Other specified counseling
Unspecified reason for consultation
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Table 7 (continued)
Contained
in
Elixhauser
Definition

Index
Weight

ICD-9CM
code

-1
1
-1
-1
-1

V6801
V681
V700
V703
V705

-1
-1
-1
-1
-1
-1

V7189
V7260
V7651
V802
V812
V8289

Condition
Disability examination
Issue of repeat prescriptions
Routine general medical examination at a health care facility
Other general medical examination for administrative purposes
Health examination of defined subpopulations
Observation and evaluation for other specified suspected
conditions
Laboratory examination, unspecified
Special screening for malignant neoplasms of colon
Screening for other eye conditions
Screening for other and unspecified cardiovascular conditions
Special screening for other specified conditions
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5. Third Manuscript: Comprehensive Comparison of Machine Learning and ModelBased Multiple Imputation Methods with Competing Sensitivity Analyses for NonRandom Missingness.

5.1. Introduction

Missing data is a frequent problem in administrative healthcare databases, and
investigators working with such data must carefully assess how to best approach this
problem in order to reduce the possibility for biased results. In Veterans Health
Administration (VHA) research to investigate the reasons for health inequities among
minority groups, missing data in key variables such as patient race and ethnicity can
pose tremendous challenges. In past years, researchers often dealt with the missing
data problem by simply conducting complete-case analysis, though this strategy could
lead to biased results unless the data were missing completely at random. More
recently, steps to attempt to assess the pattern of missingness and methods to help
achieve unbiased results such as multiple imputation are commonly seen.
When assessing missing data, it is important to determine what type of
relationship exists between the missing values and the mechanism that led to their being
missing. Three such scenarios are typically defined [71]:
a. Missing completely at random (MCAR): in this situation, the probability of missing
values does not depend on either the observed or the missing values.
b. Missing at random (MAR): In this case, the probability of missing values depends
on the observed values, but does not depend on the missing values.
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c. Missing not at random (MNAR): in this case, the probability of missing values
occurring depends on unobserved observations. The MNAR pattern cannot be
ruled out by examining the data since it exists due to information not contained in
the data, and investigators who rely on imputation methods that rely on MAR or
MCAR assumptions should take additional steps to assess whether their results
are sensitive to changes under MNAR conditions.
Numerous parametric imputation methods exist for handling data with MCAR or
MAR patterns; multiple imputation by chained equations (MICE) is one commonly used
approach due to its ability to handle multiple imputation for mixed data types [25, 26].
MICE imputes missing values from separate distributions for each variable with missing
values conditional on the other variables, but has been criticized for lacking a theoretical
basis [27], and for requiring the investigator to have advance knowledge of non-linear
relationships or collinearities between predictors [17]. Other researchers have concluded
that machine learning methods can automatically handle interactions and other concerns
while also producing inference estimates with narrower confidence limits and with more
computational efficiency. The random forest algorithm has been applied in several
multiple imputation research efforts, and involves bootstrap aggregation of numerous
independent decision trees, and can account for complex interactions and collinearities
between predictors more readily than many parametric methods, while the ensemble
voting of independent trees naturally lends itself to an efficient imputation process [28].
For example Stekhoven et al. [16] claim their multiple imputation approach (missForest)
based on the random forest method was superior to traditional statistical methods
including MICE, based on improved misclassification error rates or normalized root
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mean squared errors. Jerez et al. [29] provided a similar conclusion based on a
comparison of machine learning and statistical imputation methods. Other researchers
have incorporated machine learning methods within an existing statistical method; for
example, Shah et al [17] incorporated random forest as the multiple imputation method
within the existing MICE method and showed the new approach had a superior ability to
handle nonlinear relationships and collinearities.
Though the multiple imputation methods described above are capable of
producing unbiased results under MCAR and MAR, such results are far less likely when
a missing not at random (MNAR) condition exists. As Verbeke et al. [30] discuss, it is
possible to construct models based on MNAR assumptions, but these assumptions are
not testable since their support is not contained in the data. Further, Molenburghs et al.
[31] demonstrated that it is not possible to empirically distinguish between MNAR and
MAR situations from the data alone because for every MNAR model, it is possible to
build an MAR model with the same fit. The most common approach given these
circumstances is to conduct sensitivity analysis on MAR models to examine their stability
when MNAR assumptions are introduced [32, 33]. Though numerous approaches are
possible, two general types of sensitivity analyses are most common; these are based
on pattern mixture models [32 – 34] and selection models [35].

5.1.1 Motivating Example
This research involves a VHA cohort of 161,586 Veterans treated for traumatic
brain injury (TBI) between 2004 and 2010. In the original study, patients were followed
from the point of entry until death, loss to follow-up, or until December 2010 [48]; newer
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data was merged to extend the follow-time to December 2012. The study was approved
by the Medical University of South Carolina Institutional Review Board (IRB) and the
Ralph H. Johnson Veterans Affairs Medical Center Research and Development
committee.
The original dataset had approximately 30% missing race-ethnicity, which was
derived solely from VHA Corporate Data Warehouse (CDW) MedSAS files. The missing
proportion was reduced to 2% by merging newer information from the CDW
PatSub_PatientRace and Pat_Sub_PatientEthnicity tables, followed by Medicare raceethnicity information from the VitalStatus table. Table 8 provides the demographic and
clinical characteristics for this group, and Table 9 provides a comparison of the original
and updated race distributions. The newer race distribution appears to be more typical of
the VA population, and the combined effects of better race-ethnicity data collection [24]
and the use of Medicare data [23] provide solid support for the claim that the newer
distribution is more accurate. The updated race distribution provided strong evidence
that an MNAR pattern existed in the original data. It was then possible to compare the
results of several multiple imputation methods using the original data against results
obtained by using the updated race distribution. Since the motivating example involves
MNAR missingness, this research also involved applying several types of sensitivity
analyses to determine if such approaches provide any additional insights.
Consistent with the problems seen in the TBI cohort, several investigators have
reported the absence of race information in VHA or Medicare data may be due to nonrandom causes [4 – 6]. Depending on the timeframe being studied, the level of
missingness may be substantial in VHA data. Stroupe et al. [23] reported that 48% of
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VHA patient records had missing race-ethnicity information in 2004, but this value had
been reduced to 15% by 2012 [3] due to concerted efforts to collect this information and
due to a 2003 requirement for recording self-reported race-ethnicity rather than
observer-reported values [24]. Stroupe et al. [23] demonstrated that further
improvements were possible by merging VHA data with Medicare data; in the author’s
experience with several VHA cohorts followed through 2012 or later, the missing race
fraction can be reduced below 3% in some cases.
This research provides a unique contribution by conducting a comprehensive
comparison of multiple imputation (MI) methods under both MAR and MNAR conditions
using approaches that incorporate both machine learning and statistical methods.
Additionally, for missing race/ethnicity variables under MNAR, it examines the
effectiveness of several types of sensitivity analyses, both in simulations and in real data
application. The remainder of this aim is organized as follows: the Methods section
provides a description of the multiple imputation methods and sensitivity analyses that
are applied here, first in a simulation, and then in the TBI example. The simulation
framework is then described, including how MCAR, MAR and MNAR patterns are
generated in the simulation data. In the Results and Discussion sections the insights
gained from this work are reviewed, particularly that MNAR missingness is an extremely
challenging problem, even when the data’s MNAR mechanism is well understood.

5.2. Methods
Multiple imputation (MI) is a common approach for handling missing data. Rubin
et al. [25] provided a detailed description of multiple imputation’s advantages over
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numerous single imputation methods, particularly that MI is far more capable of
modeling the uncertainty associated with each imputed value, especially when the
reason for value being missing is unknown. Van Buuren et al. [26] discussed the
challenges for applying MI to multivariate data, where many predictors can have missing
values, and described two general approaches:
a. Joint modeling, where a joint parametric multivariate distribution is specified, and
imputations are generated in a Bayesian framework from the posterior predictive
distribution. However, this approach requires the analyst to fully specify the model,
such that any unknown interaction or nonlinearity may lead to biased results.
b. Fully conditional specification models (FCS), or Multiple Imputation by Chained
Equations (MICE): here each predictor has a distribution conditional on all of the
other predictors, with distribution parameters specific to each predictor rather than
associated with a joint distribution. This provides the important advantage of being
able to easily handle continuous and categorical data types since each predictor has
its own conditional distribution [26]. In MICE models, if Y is a matrix for n patients
and k predictors, and a portion of each predictor is missing:

y obs
are the observed observations for the jth predictor,
j
y mis
j are the missing observations for the jth predictor, and

y j is defined as all of the predictors except the jth predictor.
For P (Y j | Y j , j ) , where  j is the vector of parameters for the jth conditional
distribution, each of the k parameters and predictors is successively sampled via a
Gibbs sampler, where the tth iteration is represented by:
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j

*( t )

~ P ( j | Y j , Y j )

*( t )

~ P (Y j

Yj

( t 1)

obs

mis

| Y j , Y j ,  j )
obs

( t 1)

*( t )

M sampling processes are conducted in parallel, where M is typically 5 or 10, and
each is continued for enough iterations to ensure convergence, typically less than 20
iterations. M imputed data sets are produced, and the results are pooled as follows
[25] :
M

ˆi

i 1

M

j  

, where  j is the pooled parameter estimate.

M

Ui
where U j is the arithmetic average of the parameter estimate
i 1 M

Uj 

variances.
M

Bj  
i 1

(ˆi   j )2
M 1

where B j is the variance of the parameter estimates.

T j  U j  (1  M 1 ) * B j where T is the total pooled variance for the j th pooled
parameter.

5.2.1 MICE methods
Numerous imputation methods can be applied within the MICE framework,
including traditional statistical methods and machine learning algorithms. The MICE
package in R [72] was used to implement this framework, and separate functions were
written to incorporate the BART and neural net methods. The R program code
developed here is made available for downloading as described in Appendix A.
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5.2.1.1 MICE with logistic regression and predictive mean matching (MICE-LR)
Here, logistic regression and predictive mean matching [73] are used to form the
predictive conditional distributions for missing categorical and continuous variables. The
goal was to compare these traditional methods with the machine learning approaches
described below.

5.2.1.2 MICE with random forest (MICE-RF)
Here the random forest algorithm [28] is used during each imputation to generate
a selected number of trees based on observed data, each of which is used to make a
prediction. The imputed value is randomly selected from these predictions.

5.2.1.3 MICE with Bayesian Additive Regression Trees (MICE-BART)
BART [59] is an extension of the supervised tree-based ensemble learning
method, but unlike random forest, prior distributions are established for each tree’s
decision rules and terminal node parameters, and an MCMC algorithm is used to sample
from the posterior distribution for the ensemble of trees. The R packages BayesTree [60]
and MPBART [74] were used to generate imputed values for continuous and categorical
variables, respectively. A separate function was developed here to incorporate these
methods within the MICE framework. While this method produced reasonable results for
several iterations of the simulation, it was too slow to be viable when used on a typical
PC, though it could be useful in a parallel environment.
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5.2.1.4 MICE with neural net (MICE-NNET)
Here, a single hidden layer neural network was used during each imputation step
[14]. This machine learning approach is a non-linear statistical model that approximates
more traditional classification and regression models. The R package nnet [75] was
used to implement this method, and the size and weight decay parameters were tuned
using 10-fold cross validation with the caret package in R [76]. A separate function was
developed to incorporate neural net imputations within the MICE framework.

5.2.2 Random forest multiple imputation:
The random forest algorithm was applied as a multiple imputation method
independent of the MICE framework using the missForest package in R [16]. This
algorithm orders the predictors with missing values based on their increasing proportion
of missing values, and then imputes each variable in turn by generating a random forest
based on the observed values for the variable of interest and all corresponding
observations from the other variables. This forest is then used to impute the missing
values of the variable of interest. Once each variable has been imputed, the entire
process is repeated until a stopping point is reached based on the difference between
successive imputed datasets.

5.2.3 MNAR sensitivity analyses
Several sensitivity analyses were compared; these involve imposing MNAR
assumptions on multiple imputation models that are based on MAR assumptions. This
was of particular interest since there was strong evidence that the race-ethnicity
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covariate in the TBI example had an MNAR missingness mechanism. Each of these
methods requires the investigator to make assumptions about the missingness pattern,
though such assumptions are unverifiable from the data itself. The departure of MNAR
sensitivity analysis results from the MAR results is an indication that the MAR
assumption may not hold.

5.2.3.1 Pattern mixture model adjustment [32]
A pattern mixture model assumes that a number of missingness patterns may
exist, each with a separate joint distribution for the partially and fully observed variables.
For patients i 1,...,n and covariates Y1i and Y2i , assume Y1i has missing values with
indicator Ri , such that Ri

0 when Y1i is missing and Ri

0 otherwise. Under MNAR the

joint distribution f (Y1i ,Y2i ,Ri ) is factored as f (Y1i ,Y2i | Ri ) f(Ri ) , where the joint distribution of
the partially and fully observed variables is conditional on the partially observed variable.
Since the MNAR distribution cannot be determined from the observed data,
Carpenter and Kenward [32] suggest starting from the MAR scenario and then adjusting
the model using MNAR assumptions in order to examine whether the MAR model is
sensitive to such changes. For example, the race-ethnicity variable in the TBI data has 4
levels, and a multinomial logistic model was used to impute the missing values under
MAR assumptions, where the probability for imputing race group level j is given by:

pr( race

e

j)

dj

, where

4

e
k 1
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dk

dk

 k x'βk , for k 4 and d 4

0 , and where  and  are multinomial model

parameters.
In order to test various MNAR assumptions, shift parameters  k are introduced
for each level of the race variable, and the probability for imputing race group level j
becomes:

pr( race

j)

e

dj j

4

e

dk  k

.

k 1

Following the adjustment, we then examine how the model inference changes under the
MNAR assumption. An iterative processes is used to determine the combination of shift
parameters that best matches the MNAR assumptions.
Several other types of pattern mixture models are applied to MNAR sensitivity
analysis. One group of such methods involves data with monotone missingness
patterns, which are defined for variables y1 ,... y p , such that when y j is missing for a
given observation, then it is also missing for yk with k  j . Such observations are
grouped based on their missingness patterns, and specific groups are then used to
impute a given variable. Two such methods were attempted here; the first is termed
complete case missing values (CCMV), in which only observations with no missing
values are used [73]. The second is neighboring case missing value (NCMV), where, for
imputing values of y j , the closest group in the monotone hierarchy is used for imputation
[77]. In this closest group, observations exist for y j but not for y j 1 .
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5.2.3.2 Parameter re-weighting
In this selection model approach described by Carpenter et al. [36], the estimated
parameters determined from multiple imputation datasets generated under MAR
assumptions are reweighted to reflect MNAR assumptions. This approximation requires
that the MAR and MNAR distributions for these parameters overlap.
The MNAR assumption is incorporated in a logistic model,

logit(Pr( Ri 1 ))   'X i  Yi ,
where the outcome that patient i has an observed value for covariate Y is related to  Yi
such that large positive values of  make the odds for observing Y in this patient much
higher, while large negative values have the opposite effect. Carpenter et al. [36] show
that for m imputations and i 1,...,n1 patients who are missing covariate Y , the weight
for the m th imputation is related to a linear combination of the imputed data:
n1

wm

exp

 Yim , and the normalized weight is wm

i 1

wm
m

. The imputed results are

wm
i 1

pooled in a manner similar to that developed by Rubin [25]:

ˆ MNAR

M

wm ˆ m , where ̂ m is the MAR parameter estimate for the m th imputation;

m 1
M

U   wmˆm2 where U is the weighted mean of parameter estimate variances;
m 1
M

B   w m ( ˆm  ˆMNAR ) 2 where B is the between variance of the parameter estimates.
m 1

T  U  (1  M 1 )* B where T is the total pooled variance.
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While Carpenter et al. demonstrated this approach for continuous outcomes with MNAR
missingness, Heraud-Bousquet et al. [78] provide additional insights for applying the
weighting method to datasets with missing covariates, including categorical variables.

5.2.1 Simulation Study
A simulation study was conducted in order to compare the multiple imputation
methods described above against results from complete-case analysis under MCAR,
MAR and MNAR scenarios. 1000 datasets with 5000 observations each were selected
by randomly sampling with replacement from a Veterans Administration dataset that
consisted of approximately 37,000 complete case observations from a diabetes cohort.
Though it would have been possible to fully simulate such data, a resampling approach
was used instead to help ensure that the complex structures and associations found in
real patient observations were also present in the synthetic datasets. As demonstrated
by Marshall et al. [37] and Gebregziabher et al. [38] this approach is reasonable when
the original dataset is large enough to help assure independence between samples.
The outcome was mortality within the 10-year study timeframe, and covariates
included demographic measures such as age (continuous variable), gender, racialethnic group (non-Hispanic white, non-Hispanic black, Hispanic, other), marital status
(married or single), and urban-rural location indicator. Clinical indicators included the
percentage of disability connected to military service, the patient’s mean medication
possession ratio (mean MPR), and the patient’s mean glycated hemoglobin (mean A1c)
level during the study period. The variables with missingness imposed were racial-ethnic
group, mean A1c, and mean MPR.
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MCAR, MAR and MNAR missingness scenarios were separately imposed on
each bootstrapped dataset, and for each of these in turn, versions were generated with
10%, 30%, or 50% missing values. Complete case analysis was conducted on each of
these nine datasets, along with multiple imputation by the four methods discussed
above. Missing data patterns were generated by the following rules [79]:
1) Missing Completely at Random (MCAR): missing observations for the racial-ethnic
group, mean MPR, and mean A1c variables were determined on a completely
random basis.
2) Missing at Random by rank (MAR): when the patient died, the racial-ethnic group
value was more likely to be missing; when the patient was single, the mean MPR
variable was more likely to be missing; when the patient lived in a rural location, the
mean A1c variable was more likely to be missing.
3) Missing Not At Random (MNAR): when the patient was in the non-Hispanic black or
Hispanic groups and died during the study window, the racial-ethnic value for that
patient was more likely to be missing. When mean MPR or mean A1c were above
their respective medians, each was more likely to be missing.

Once missing values were established using the rules described above, further
adjustments were made on a random basis as needed to achieve the required total
proportion of observations with any missing values. Finally, each dataset was tested
using logistic regression to verify that the required missingness structure had been
generated. Binary indicators were generated for each of the variables with missing
values, such that a ‘0’ meant the value was missing. These indicators served as the
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outcomes in the three logistic regression models. For each type of missingness, the
significance of the estimated parameters was evaluated, and a given dataset was
accepted if odds ratios for the parameters of interest were at least 1.5. For example, in
the MNAR case, predictors of interest were the non-Hispanic black and Hispanic groups,
and mortality.
Imputation methods were compared using the following statistics:
1) Relative bias: (ˆ  ˆ ) / ˆ , where ̂ and ˆ o are the generalized linear model
o

parameter estimates based on the imputed data and the full dataset of 37,506
complete cases, respectively.
2) Efficiency: var(ˆ )/ var(ˆ )
o

3) Root mean square error:

( ˆ  ˆ o )2  ˆ 2 , where ˆ 2 is the estimated variance of

the parameter estimate from the model based on imputed data.
4) Coverage probability: the probability based on 1000 bootstrapped iterations that the
95% confidence interval for the parameter estimate contains ˆ o .
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5.3 Results
5.3.1 Simulation results:
Table 8 provides a summary of clinical and demographic characteristics for the
diabetes (simulation) cohort. Figures 9 and 10 provide relative bias results for MAR and
MNAR scenarios for those variables on which missingness was imposed: non-Hispanic
black and Hispanic groups and for mean medication possession ratio (mean MPR) and
mean glycated hemoglobin (mean A1c). Figure 11 provides coverage probability results.
When confidence intervals are compared in the MAR scenario, MICE with
random forest imputation appeared to provide the least biased results when compared to
complete case analysis, particularly at 50% missingness.
In the MNAR scenario, for the non-Hispanic black and Hispanic groups, all
multiple imputation results were biased. However, for the two continuous variables, the
MICE methods provided reasonable results. Coverage probability under MNAR is very
poor for both race groups regardless of the MI method, but for mean MPR and mean
A1C, coverage probability remains high. The missForest MI method appears to lag the
other MI methods in coverage performance.
Figure 12 provides simulation results for MNAR sensitivity analyses, which were
performed on multiple imputation results from data with 30% MNAR missingness in the
non-Hispanic black and Hispanic groups. Under pattern mixture model 1 and selection
model parameter weighting, shift parameters were iteratively adjusted to achieve the
lowest relative bias when compared against the true race distribution. Under pattern
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Table 8: Demographic and clinical characteristics of the diabetes (used in simulation) and the
traumatic brain injury cohorts.

Variable
Mean age (sd)
Mortality rate (%)
Gender (%)
Marital status (%)
Race/ethnicity (%)1

Rural location (%)
More than 50% servicerelated disability (%)
TBI severity

Mean HbA1c (mean/sd)3
Mean MPR (mean/sd)4

Level

Diabetes
Cohort

TBI
Cohort

n = 37,506

n = 161,586

----male
non-married2
married
non-Hispanic white
non-Hispanic black
Hispanic
other
missing
---

73.4 (5.4)
45.6
98.7
28.2
71.8
80.9
9.9
5.1
4.0
--39.0

49.9 (17.9)
23.9
93.7
57.9
42.1
55.9
13.0
1.9
2.6
26.6
---

--less severe
moderate
highest
-----

7.3
------7.2 (1.1)
0.79 (0.2)

23.3
22.7
27.5
49.8
-----

1

original race-ethnicity distribution in TBI cohort
includes single, divorced, widowed, never married
3
mean glycated hemoglobin
4
mean medication possession ratio (number of days of diabetes medication supply divided by 365 days (or if
deceased during that year, the number of days until death) over the study period
2

mixture model 2 (PMM-2), shift parameters were iteratively adjusted in order to provide
the closest match in the imputed data with the true race distribution proportions for each
group. While PMM-1 results did achieve low relative bias, the imputed datasets had
substantially more non-Hispanic black and Hispanic members than seen in the original
data. In PMM-2 on the other hand, when imputed datasets had approximately the same
race distribution as in the original data, relative bias remained high. Bias was also high
after parameter reweighting analysis.
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Table 9: comparison of original and updated race-ethnicity distributions for the traumatic brain
injury (TBI) data. NHW is non-Hispanic white, NHB is non-Hispanic black. Under the original
distribution, 26% of patients were classified as missing race-ethnicity information; under the
newer distribution, which incorporated more recent VHA data sources and merged Medicare
information, the percentage of missing values was reduced to approximately 2%. The new race
distribution showed that race was likely missing under MNAR conditions in the original data (see
table 10).

Original distribution
Updated
Distribution

NHW

NHB

NHW
NHB
Hispanic
Other
Missing

83190
478
5565
1024
0

335
19911
385
444
0

621
42
2339
117
0

0
0
0
4231
0

29562
5795
4267
0
3280

113708
26226
12556
5816
3280

Total
(percent)

90257
0.56

21075
0.13

3119
0.02

4231
0.03

42904
0.27

161586

Hispanic

Other

Missing

Total

(percent)
0.70
0.16
0.08
0.04
0.02

5.4.2 Results from TBI application:
The original and updated race and ethnicity distributions for the TBI group are
shown in Table 9. By merging updated VHA and Medicare information, the proportion of
missing values was reduced from about 26% to 2%. Of note, 34% of the Hispanic group
in the updated distribution was in the missing category under the original distribution,
compared with 26% and 22% for non-Hispanic whites and non-Hispanic blacks,
respectively. Further, 47% of the Hispanic group had been misclassified to a different
group originally, substantially higher than for other groups.
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Figure 9: Simulation results: relative bias with 95% confidence intervals for four multiple
imputation methods compared to complete case analysis under MAR missingness. In this
scenario, when the patient died, the racial-ethnic variable was more likely to be missing; when the
patient was single, mean medication possession ratio (mean MPR) was more likely to be missing;
when the patient lived in a rural location, the mean glycated hemoglobin (mean A1c) variable was
more likely to be missing. Based on relative confidence intervals, MICE with random forest
imputation appeared to provide the least biased results when compared to complete case
analysis, particularly for at 50% missingness.
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Figure 10: Simulation results: relative bias with 95% confidence intervals for four multiple
imputation methods compared to complete case analysis under MNAR missingness. In this
scenario, when the patient was in the non-Hispanic black or Hispanic groups and died during the
study window, the racial-ethnic variable for that patient was more likely to be missing. When
mean medication possession ratio (mean MPR) or mean glycated hemoglobin (mean A1c) were
above their respective medians, each was more likely to be missing. For the non-Hispanic black
and Hispanic groups, all of the multiple imputation results were biased. For the two continuous
variables, however, the MICE methods provided reasonable results.
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Figure 11: Simulation results: coverage probability for each multiple imputation (MI) method and
missingness scenario. For the non-Hispanic black and Hispanic groups, coverage probability
under MNAR is very poor regardless of the MI method. For the continuous variables, coverage
probability remains high under MNAR. The missForest MI method appears to lag the other MI
methods in coverage performance.
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Figure 12: Simulation results for MNAR sensitivity adjustment: comparison of relative bias for
three MNAR sensitivity analyses, all with 30% missingness. Sensitivity adjustments were made to
multiple imputation results based on multinomial logistic regression models. These are compared
with the unadjusted results (MAR imputation, in black) and with complete case analysis (light
blue). Under pattern mixture model 1 and selection model parameter weighting, shift parameters
were iteratively adjusted to achieve the lowest relative bias when compared against the true race
distribution. Under pattern mixture model 2 (PMM-2), shift parameters were iteratively adjusted in
order to provide the closest match in the imputed data with the true race distribution proportions
for each group. While PMM-1 results were substantially improved, the imputed datasets had
substantially more non-Hispanic black and Hispanic members than seen in the original data. In
PMM-2, when imputed datasets had approximately the same race distribution as in the original
data, relative bias remained high. The parameter reweighting analysis did not succeed because
the distribution of MNAR coefficients fell outside the distribution of the MAR coefficients for any
plausible adjustment.
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Table 10 summarizes the association between missing race in the TBI data and
other covariates. Of note, the association between the updated race-ethnicity variable
and missing race in the original data shows indications of an MNAR pattern in the
Hispanic group, with OR = 1.47 (95% CI, 1.41 - 1.52).
Table 11 compares the mortality odds ratios based on the updated race-ethnicity
variable with those for complete case analysis in the original data, multiple imputation
results, and three MNAR sensitivity analyses. The complete case odds ratio for
Hispanics is 1.22 (95% CI, 1.11 - 1.33) compared with non-Hispanic whites, while the
OR based on the updated race information is protective: 0.73 (95% CI, 0.69 - 0.77). In
the multiple imputation comparison, the MissForest results appear to be biased lower for
all three race groups, while the other multiple imputation methods provided generally
similar results, and none differed substantially from complete case analysis. In the first
pattern mixture model analysis (PMM-1) and selection model parameter weighting, shift
parameters were iteratively adjusted to achieve the lowest relative bias when compared
against the updated race distribution. The PMM-1 Hispanic OR result was 0.85 (95% CI:
0.82 – 0 .88), but the imputed data contained an average of 28% Hispanic patients,
compared with the actual value of 8%. The parameter weighting Hispanic result was
nearly identical to the complete case result. Under PMM-2, shift parameters were
iteratively adjusted in order to provide the closest match in the imputed data with the
updated race distribution; here the Hispanic group OR was 1.04 (95% CI, 0.96 - 1.12),
lower than the complete case result.
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Table 10: Odds ratios for the association between missing race-ethnicity in the original TBI
dataset and other covariates. The race-ethnicity predictor here is the updated, or “true” race
determined with newer information. The strong association between the Hispanic group and
missing race is strong evidence for an MNAR mechanism.

Variable
Age
Gender
Marital Status
Race-ethnicity1

TBI severity

Level
Female
Married
Non-married
NHW
NHB
Hispanic
Other2
less
moderate
most

Homeless
Death
Disability >50%

OR (95% CI)
1.00 (1.00, 1.00)
1.08 (1.03; 1.13)
--0.88 (0.86; 0.91)
--0.91 (0.78; 0.83)
1.47 (1.41; 1.52)
0
--1.27 (1.23; 1.31)
1.34 (1.30; 1.39)
0.41 (0.36; 0.47)
0.78 (0.75; 0.80)
0.82 (0.79; 0.85)

1

Using updated race-ethnicity distribution to predict missing values
in older race-ethnicity data
2
No patients were missing in the ‘other’ category

5.4 Discussion

Three MICE methods and the missForest algorithm were compared against
complete case analysis in MCAR, MAR and MNAR scenarios and several types of
MNAR sensitivity analysis were then applied, both in a simulation and in an application
to TBI data. One specific goal was to examine competing methods for approaching the
problem of missing race-ethnicity information typically seen in VHA datasets. In
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Table 11: Traumatic brain injury (TBI) example: comparison of mortality odds ratio based on the
updated race distribution against the odds ratios from complete case analysis, multiple imputation
(MI), and MI with MNAR sensitivity analyses using the original TBI data, where approximately
26% of the race-ethnicity data was missing. Under PMM-1 and selection model parameter
weighting (“weighted”), shift parameters were iteratively adjusted to achieve the lowest relative
bias when compared against the updated race distribution. Under pattern mixture model 2 (PMM2) shift parameters were iteratively adjusted in order to provide the closest match in the imputed
data with the updated (“true”) race distribution.

Analysis

OR based on
updated race
distribution
Complete
Case
Analysis

Multiple
imputation

MI with
MNAR
sensitivity
analysis

MI Type

MNAR
sensitivity
analysis

Mortality OR by race-ethnicity group
(95% CI)
Ref group is NHW
NHB

Hispanic

Other

---

---

0.80 (0.77;
0.83)

0.73 (0.69;
0.77)

0.92 (0.85;
1.00)

---

---

0.79 (0.75;
0.83)

1.22 (1.11;
1.33)

0.71 (0.64;
0.79)

0.76 (0.73;
0.80)
0.84 (0.72;
0.97)
0.85 (0.83;
0.88)
0.62 (0.60;
0.65)
0.82 (0.79;
0.85)
0.80 (.076,
0.77)
0.79 (0.76;
0.83)

1.19 (1.10;
1.30)
1.18 (0.86;
1.51)
1.13 (1.02;
1.27)
0.93 (0.89;
0.98)
0.85 (0.82;
0.88)
1.04 (0.96;
1.12)
1.21 (1.11;
1.31)

0.71 (0.65;
0.78)
0.78 (0.55;
1.08)
0.71 (0.64;
0.81)
0.35 (0.32;
0.38)
0.67 (0.60;
0.74)
0.68 (0.61;
0.75)
0.67 (0.60;
0.75)

Multinomial
logistic
regression
Random
Forest

-----

Neural Net

---

MissForest

--PMM-1

Multinomial
logistic
regression

PMM-2
Weighted

particular, this work examined whether MI methods that incorporate machine learning
algorithms have any performance advantage, and whether any sensitivity analyses were
more successful under MNAR. The TBI example provided a good opportunity for this
comparison.
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As expected, under MCAR and MAR conditions in the simulation, the MICE
methods and miss Forest imputation provided reliable results with reasonably low bias
and good efficiency when compared with complete case analysis. In particular, MICE
with random forest imputation appeared to have a slight performance advantage, while
the missForest method appeared to lag.
Under MNAR, where the scenario led to African American and Hispanic patients
who died were more likely to have missing racial-ethnic group information, relative bias
and coverage probabilities were extremely poor for those groups by all imputation
methods. In contrast, performance statistics were substantially better for imputed values
for mean A1c and mean MPR. This difference may be due to the complex MNAR
mechanism for the race groups, which also involved the outcome. It may also be due in
part to the data structure: the two racial groups were small compared to the reference
group, and there was thus less information available in the data for making effective
imputations. For the mean A1c and mean MPR variables there was far more information
available even with 50 percent of observations missing, and the imputation algorithms
appeared to more effective.
The simulation demonstrated the challenges for applying MNAR sensitivity
analysis, even in the unusual situation where the exact missingness mechanism was
known. When the pattern mixture model was used to attempt to minimize the relative
bias, the imputed datasets contained unrealistic race-ethnicity distributions. Other
sensitivity analyses were less successful. In particular, the selection model weightedparameter method failed because the distribution for the MNAR parameter estimates fell
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outside the distribution for the MAR parameter estimates. Carpenter et al. discuss this
limitation of the weighting method [36] .
Many of the conclusions drawn from the simulation were repeated with the TBI
example. The multiple imputation methods produced relatively unbiased results for the
non-Hispanic black group, for which missingness was generally MAR. On the other
hand, in the Hispanic group, missingness was MNAR and biased results were seen as a
result. In the TBI sensitivity analyses, though the pattern mixture model in which relative
bias was minimized (PMM-1) appeared to be generally successful, the Hispanic group in
the imputed results was 3.5 times larger than actual. In the pattern mixture model for
which the goal was to match the true race distribution within the imputed data (PMM-2),
biased results were still seen.
Further work to better understand the MNAR mechanisms that led to the missing
race data could help inform future MNAR sensitivity analyses; however, there may be
limits to how much can be achieved given the challenges seen in the simulation, where
the MNAR situation was fully described.
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6. Summary and Conclusions

6.1 Summary
This work was motivated by two challenges that are commonly experienced by
investigators who work with large VHA administrative healthcare datasets. These
challenges included the need for better ways to account for the patient’s disease burden
based on diagnostic codes, and the need for improved ways to handle missing data,
particularly when the missingness exists in important covariates.
In the first manuscript, improved models for summarizing a patient’s disease
burden were developed by applying seven machine learning and statistical methods.
Each method provided more accurate predictions than models based on the Elixhauser
index, and the pooled model, based on the combined predictions of the other six
methods, usually had the best predictive performance.
In the second manuscript, an improved comorbidity summary score was
developed based on the variable importance measures from the top performing models
in the first manuscript. Three large VHA cohorts were used to both train these models
and to validate the score. When compared against models based on the Elixhauser
index, the score demonstrated more accurate predictive performance.
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In the third manuscript, four multiple imputation methods were compared using
simulations and applications to real data under several types of missingness. The
effectiveness of MNAR sensitivity analyses based on pattern mixture models and
selection models was carefully examined, with implications for other VHA investigators
who work with similar datasets.

6.2 Discussion and Conclusions
The following paragraphs provide a summary of the insights and conclusions
drawn from this research:

6.2.1 Comparing machine learning to traditional statistical methods.
One goal in the first and third aims was to examine whether machine learning
methods offered any advantages over traditional statistical approaches, particularly in
their ability to automatically account for complex interactions and non-linear effects.
In the first aim, where the goal was to develop better ways to account for disease
burden, predictive performance was compared between three machine learning and
three statistical methods. The top performers (excluding the pooled model) included two
machine learning methods (random forest and Bayesian additive regression trees) and
one statistical method (elastic-net penalized logistic regression).
In the third aim, where several multiple imputation methods were compared,
machine learning algorithms were incorporated in three models, while the fourth relied
on statistical methods for imputation. Here, the top performer in many situations was the
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model with random forest incorporated within the multiple imputation with chained
equations (MICE) framework, but MICE models using logistic regression and predictive
mean matching often achieved similar results. Random forest was far less successful as
a stand-alone multiple imputation method, and neural net imputation within the MICE
framework also performed poorly.
Overall, neither machine learning nor traditional statistical methods offered a
clear advantage over the other group in these applications, and the investigator should
carefully consider a wide variety of methods that are not limited to any particular type.

6.2.2 Problems with modeling the correlation structure inherent in the ICD hierarchy.
One goal in the first aim was to take advantage of the hierarchy established by
the ICD system, such that if data were sparse for a particular ICD code, information from
similar codes within the same hierarchy could be used to approximate the effects for the
sparse predictors. This approach was incorporated in the Probability Based Features
models (dropped prior to completion of manuscript 1) and Modeled Averaged
Regression Coefficients models. Both were among the weakest performing methods,
and the original assumption is likely false that the correlation structure imposed by the
ICD hierarchy can be used to make valid assumptions about sparsely populated ICD
conditions.

6.2.3 Performance advantages of ensemble models.
In the first aim, the model based on the pooled predictions of the other models
had the strongest predictive performance of any model. Dietterich [19] described why an
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ensemble of accurate and diverse classifiers is likely to perform better than the individual
models. A somewhat different ensemble approach was used in the second aim, when
the variable importance measures for the top three models applied to four populations
were combined such those predictors with importance measures falling in the top 50% in
all 12 results were selected for use in the summary score.

6.2.4 New population insights based on variable importance models.
The variable importance results developed in the first and second aims
demonstrated that a number of conditions not included in the Elixhauser index were
highly predictive for five year mortality. As discussed in the second manuscript,
Elixhauser developed the index in order to predict short-term events including in-hospital
mortality, hospital charges, or length of stay, and she thus excluded a wide range of
conditions from her index [2] since they were not associated with short-term events. It
thus was not surprising to find a number of conditions associated with the patient’s
functional status were strongly associated with longer-term outcomes such as five year
mortality. These included Alzheimer’s disease, senile dementia, hearing loss, persistent
mental disorders, memory loss, falls, lack of household assistance, and urinary
incontinence.

6.2.5 Summary score weights based on statistical rather than clinical importance.
The variable importance results in the second aim highlighted that ICD codes for
potentially harmful conditions are not always associated with mortality. This is often
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related to the codes’ primary use as billing mechanisms, such that codes for less serious
conditions are often not recorded when the patient is critically ill since other conditions
are more likely to be the main drivers of the patient’s medical costs. As a result, it would
be possible to falsely conclude from ICD data that high blood pressure is protective
against mortality [2]. Rather than exclude these associations, which are accurate from a
statistical view, codes that predicted survival were instead included in summary score
with a negative weighting, even when this appeared to contradict clinical evidence. As a
result, many patients had an overall negative score, meaning more of their highly
predictive ICD codes were associated with survival rather than mortality. Failure to take
advantage of this artifact related to the ICD billing system would lead to substantially
worse predictive performance. The disadvantage of such an approach is that the
summary score does not provide a clinical picture of the patient’s comorbidities; instead,
it provides a score used to predict mortality based on a comparison with millions of other
Veterans for whether the patient has specific conditions that were most predictive in this
population.

6.2.6 Unbiased imputation of continuous variables under MNAR
In the third aim, MNAR scenarios were simulated for two continuous variables
and for two of the four levels in a nominal categorical variable (race/ethnicity). None of
the multiple imputation methods could provide unbiased results for the categorical
variable, but several methods (random forest within MICE and logistic
regression/predictive mean matching within MICE) provided unbiased results with
slightly narrower confidence intervals than complete case analysis, even when 50% of
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values were missing. This difference may be due to the complex MNAR mechanism for
the race groups, which also involved the outcome. It may also be due in part to the data
structure: the two racial ethnic groups were small compared to the reference group, and
there was thus less information available in the data for making effective imputations.
For the mean A1c and mean MPR variables there was far more information available
even with 50 percent of observations missing, and the algorithms were more effective. In
summary, unbiased imputation under MNAR may be possible in some situations, but the
investigator must be careful to conduct sensitivity analysis to try to verify the results are
reasonable.

6.2.7 Challenges for conducting sensitivity analyses under MNAR
Two types of sensitivity analysis were performed on imputed values in the third
aim; these analyses were based on pattern mixture models and selection models (see
section 2.3.9). In both the simulations and the application to real data, the MNAR
mechanism was well understood. For the real data, this unusual situation existed
because different sources of race/ethnicity information became available after the initial
cohort had been formed, such that a more accurate variable with substantially lower
missingness could be determined for comparison against the original. Thus, sensitivity
analysis could be applied in situations where “true” parameter estimates existed. While
the pattern mixture model approach could be used to produce reasonable inference, the
imputed datasets under those conditions contained unrealistic race-ethnicity
distributions. The selection model weighted-parameter method failed because the
distribution for the MNAR parameter estimates fell outside the distribution for the MAR
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parameter estimates. While this work did not provide a solution for the MNAR
race/ethnicity challenge likely faced by many investigators, it did provide important
insights into the specific challenges researchers face when the reason for missingness is
related to the missing data itself, or to other unknown variables.

6.3 Limitations
Three Veteran populations were studied, with an average age of 73.7, and with
an average of 4.2% women. Further work is needed to determine if the results from the
first two aims could be generalized to a wider population. The results of the third aim
involving missing data are less likely to be affected by the distinct populations.
While each aim considered a wide variety of available methods, these were
limited to those which could be completed in a reasonable time on a typical desktop
computer (64 bit machine with 16GB RAM, 2.56GHz processor) or on a shared server
(64 bit server with 16GB RAM and a 2.36 GHz processor). While this limitation helped to
ensure these methods can be directly applied by most investigators, additional methods
could be attempted in a parallel environment.
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6.4 Future Work
Numerous areas for additional work were noted. Since the original dissertation aims
were developed to support specific research problems encountered in work with VHA
administrative healthcare data, these future work goals are also well suited for
application to VHA research.
1) In the second aim, the summary score algorithm involved a simple weighting
scheme, and this was validated only on Veteran populations. Additional work is planned
in the following areas:
a. The score will be validated on other groups, including non-Veteran
populations to help determine generalizability beyond the older, male population in which
the score was originally developed. Other weighting schemes could boost predictive
performance, and validation in other outcomes such as one-year mortality could widen
its applicability.
b. The score’s definition will be expanded to include other types of
administrative data, including vital signs, health services utilization, medications, and
laboratory tests using a similar approach to that developed for the first two aims; a wide
variety of methods will be examined for each of the data types, and competing variable
importance measures will be used to identify a group of variables with the strongest
predictive performance. This expanded score will be compared to existing measures,
such as the Care Assessment Needs Score [80].
c. Since the score is similar in some ways to a propensity score [81],
applications for its use in adjusting for confounding and selection bias will be examined.
For example, in studies that examine disparities in health outcomes, the comorbidity
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score could be used to match patients by various exposures to attempt to control for
selection bias or confounding.
2) Expanding further on the third aim, the following additional areas concerning
multiple imputation merit further work:
a) Other multiple imputation methods could be applied to the missing
race-ethnicity problem for comparison against the existing results. For example,
Gebregziabher and DeSantis [82] and Vermunt et al. [83] apply latent class models
within the multiple imputation framework. Such models are typically limited to only
categorical data, and it would be difficult to apply them directly to most administrative
healthcare datasets. However, LCMI may still be a useful tool for investigating the
missing race-ethnicity problem.
b) Bayesian Additive Regression Trees (BART) could be tested as the
imputation method within the MICE framework within a parallel computing environment.
While this method was successfully implemented in the third aim, it was too slow in a
single-processor environment to be feasible.
3) The MNAR sensitivity analyses conducted as part of the third aim were limited
to missing race-ethnicity, and thus involved only a multi-level, nominal categorical
variable. This work will be expanded to include all variable types and a wider range of
methods in order to better understand the limitations of current work in this area, and to
look for areas where methodological development is warranted. The following
paragraphs provide an expanded summary of possible approaches when MNAR
conditions are suspected, beyond those already considered in the third aim:
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a) The first approach involves developing a joint model that attempts to
incorporate the MNAR mechanism. Such a joint distribution may be very complex and
inference may require MCMC methods. As Molenberghs and Lesaffre discuss [33],
such models are based on untestable assumptions, and may be very sensitive to minor
changes in such assumptions. For these reasons sensitivity analyses based on models
developed from an MAR basis are more commonly seen.
b) Another option is to consider the addition of auxiliary variables, which
may help to explain why missingness occurred, but are otherwise not useful for
explaining the outcome. Raykov et al. describe that such variables could be included in
the maximum likelihood or multiple imputation models, and could perhaps help the
models meet the underlying MAR assumption [84]. However this approach, like the
basic MNAR models in paragraph (1), may still rely on untestable assumptions, and it
may not be possible to identify the correct auxiliary variables to produce the needed
improvement.
c) The most common approach is to conduct sensitivity analyses on
MAR models to test whether the inference from models is sensitive to the imposed
changes. The analyst must select what types of analyses to conduct based on a “best
guess” for what caused the missingness. As discussed in the third aim, most sensitivity
analyses are broadly grouped into selection model or pattern mixture model approaches
[32, 85]. The data type will further dictate how the analyses are conducted.
i) Sensitivity analyses based on pattern mixture models typically
involve one or more shift parameters. For continuous variables, scale factors and shift
factors are multiplied by or added to the imputation results. For categorical data, shift
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parameters are applied within the appropriate generalized linear model; for example, in
logistic regression, the shift represents the change in the log-odds that a specific level of
the variable is observed. Different shifts could be imposed for each level of the variable
[86].
ii) Selection model sensitivity analyses can take numerous forms;
one method was examined in the third aim [36]. Another approach involves developing
a measure of local influence. Here the goal is to produce an index that quantifies how
much an MAR model deviates from its MLE when it is perturbed towards an MNAR
condition. Verbeke et al. [30] derived this approach for normally-distributed longitudinal
data, and Troxel et al. demonstrated a similar method for generalized linear models [87].
While Verbeke’s approach examines the model’s behavior at the individual level, Troxel
is concerned with behavior at the group level. Troxel’s Index of Sensitivity to nonignorability (ISNI) is easily implemented since it relies only on determining the MLE from
complete case data, and a separate model for predicting missingness.
d) Summary and description of future work: while much work is available
in the literature concerning the development of MNAR models (paragraphs a and b
above), there is a strong consensus that this effort is less likely to be successful because
the basic assumptions for such models are untestable. Sensitivity analyses continue to
offer the most promise, and my work will focus on two areas:
i) Pattern mixture model adjustments for other variable types
besides nominal categorical data, particularly continuous variables.
ii) Local influence analyses, particularly as described by Troxel
[86].
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APPENDIX A: EXAMPLES OF R AND SAS PROGRAMS DEVELOPED TO SUPPORT
RESEARCH AIMS

A.1 Introduction
This Appendix provides a description of the software program files that were developed
to support this research. These files and supporting sample datasets are available in
GitHub (user: rcccward, respository: comorbidity-models). All R functions described in
this appendix were developed using R version 3.2.3 [88]. SAS macros were developed
using SAS software (SAS Institute Inc., Cary, NC), version 9.4.

A.2 Comorbidity models development (first manuscript)
A.2.1 Description (models_func)
This R function (models_func) applies the top-performing methods applied in the
first aim to summarize disease burden from ICD-9-CM data by training and validating
models and comparing each method’s predictive performance with models based on the
Elixhauser index using AUC, sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), and net reclassification improvement statistics for
events and non-events. Methods include elastic-net regularized generalized linear
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model, random forest, Bayesian additive regression trees, and an ensemble model
based on the pooled predictions of the other models.

A.2.2 Usage (models_func)
models_func(patient_dat, binary_dat, elixmat, iterations, size, covariate_flag)

A.2.3 Arguments (models_func)
patient_dat

Dataframe containing the outcome and covariates such as race,
age, gender, marital status, and clinical variables. Categorical
variables should be stored as factors

binary_dat

Dataframe containing binary ICD-9 data, one row per patient and
one column per unique ICD-9 code. Variables should be stored as
factors. The column names should list each 5 digit code.

elixmat

Dataframe containing the Elixhauser-Quan comorbidities, one row
per patient, and one binary column for each of the 31
comorbidities, stored as factors. Alternatively, the user could
establish a different comparison comorbidity measure in place of
the Elixhauser index, where each column serves as an
independent predictor in the comparison model.

iterations

The number of bootstrapped training and validation samples to be
generated in order to determine the distribution of the comparison
statistics.

size

The number of observations within each bootstrapped sample.
108

covar_flag

A flag indicating whether patient covariates from patient_dat
should be included in the models, or whether inference should be
based solely on ICD-9 information.

A.2.4 Output objects (models_func)
A single list is returned containing the following objects:
meanvarimpRF

A vector of the random forest ICD-9 variable importance
measures, with one measure for each column of binary_mat.

meanvarimpBART

A vector of the Bayesian additive regression trees ICD-9 variable
importance measures, with one measure for each column of
binary_mat.

meanvarimpREG

A vector of the elastic-net regression ICD-9 variable importance
measures, with one measure for each column of binary_mat.

output

A matrix containing the performance statistics and their 95%
confidence limits for models based on the Elixhauser index,
random forest, BART, elastic-net, and the pooled model. Statistics
include AUC, sensitivity, specificity, Brier score, net
reclassification error (NRI) for events and non-events.

train_id, test_id

Indices of training and validation observations used in partitioning
the dataset such that the same partition is used during summary
score development (score_fn, below).
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A.2.5 Examples (models_func)
Sample datasets patient_dat, binary_dat, and elixmat are provided with the program
code in GitHub. These are simulated observations for a diabetes patient population
similar to the Veteran population studied in aims 1 – 3. The following console summary
is provided in addition to the information stored in the returned object:

pred_out<-models_func(dat,binary, elixmat,iterations, size, covar_flag)
Model Performance Comparison (covariates not included in model)
1000

iterations

size =

2000 patients
Elix

RF

BART

REG

Pool

AUC-UCL

0.709

0.834

0.841

0.840

0.854

AUC

0.684

0.820

0.823

0.823

0.837

AUC-LCL

0.663

0.799

0.806

0.803

0.819

sens-UCL

0.537

0.702

0.748

0.709

0.733

sens

0.485

0.672

0.719

0.663

0.701

sens-LCL

0.424

0.627

0.680

0.609

0.660

spec-UCL

0.813

0.841

0.802

0.842

0.834

spec

0.772

0.818

0.774

0.820

0.810

spec-LCL

0.731

0.788

0.739

0.794

0.785

Brier-UCL

0.228

0.182

0.178

0.180

0.173

Brier

0.222

0.172

0.171

0.171

0.164

Brier-LCL

0.215

0.164

0.161

0.162

0.155

NRIevent-UCL

-----

0.246

0.280

0.225

0.273

NRIevent

-----

0.188

0.234

0.178

0.217

NRIevent-LCL

-----

0.142

0.189

0.119

0.169

NRInonevent-UCL

-----

0.088

0.041

0.095

0.079

NRInonevent

-----

0.045

0.002

0.048

0.038

NRInonevent-LCL

-----

0.018

-0.030

0.016

0.008
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A.3 Summary score development (second manuscript)
A.3.1 Description (score_fn)
This function demonstrates the method used in the second aim to develop a
summary score based on variable importance measures from the top performing models
in aim 1. Those ICD-9 codes with importance measures in the top 50% among all
models were included in the summary score, and codes associated with mortality and
survival were assigned weights of +1 or -1, respectively. The patient’s score is a simple
weighted sum of how many of the selected ICD-9 codes were found in the patient’s
record. Score performance was compared to models based on the Elixhauser-Quan
index using AUC, sensitivity, specificity, Brier Index, and net reclassification index
statistics. Note that the models function (models_func) described above must be run first
since score_fn requires variable importance rankings from models_func in order to
develop the summary score.

A.3.2 Usage (score_fn)
Score_fn(models_out, patient_dat, binary_dat, elixmat, iterations, size, covar_flag)

A.3.3 Arguments (score_fn)
models_out

This is the list object produced by models_func, above.

patient_dat

Dataframe containing the outcome and covariates such as race,
age, gender, marital status, and clinical variables. Categorical
variables should be stored as factors.
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binary_dat

Dataframe containing binary ICD-9 data, one row per patient and
one column per unique ICD-9 code. Variables should be stored as
factors. The column names should list each 5 digit code.

elixmat

Dataframe containing the Elixhauser-Quan comorbidities, one row
per patient, and one binary column for each of the 31
comorbidities, stored as factors. Alternatively, the user could
establish a different comparison comorbidity measure in place of
the Elixhauser index, where each column serves as an
independent predictor in the comparison model.

iterations

The number of bootstrapped training and validation samples to be
generated in order to determine the distribution of the comparison
statistics.

size

The number of observations within each bootstrapped sample.

covar_flag

A flag indicating whether patient covariates from patient_dat
should be included in the models, or whether inference should be
based solely on ICD-9 information.

A.3.4 Output objects (score_fn)
Score_fn produces a list with the following objects:
comorbidities

This is a list of the ICD-9 codes from binary_mat which were
included in the summary score.

weights

This is the weights (+1 for mortality, -1 for survival) assigned to
each code in the score.
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output

Matrix of performance statistics and 95% confidence limits for the
model based on the Elixhauser-Quan index and the summary
score.

A.3.5 Examples (score_fn)
Console output:
>score_run<-score_fn(pred_out,dat,binary, elixmat, iterations,size,
covar_flag)
Score performance (covariates not included in model)
1000

iterations
Elix

Summary Score

AUC-UCL

0.693

0.827

AUC

0.676

0.816

AUC-LCL

0.663

0.806

sens-UCL

0.512

0.719

sens

0.472

0.700

sens-LCL

0.436

0.681

spec-UCL

0.795

0.796

spec

0.773

0.781

spec-LCL

0.744

0.765

Brier-UCL

0.228

0.179

Brier

0.224

0.174

Brier-LCL

0.219

0.169

NRIevent-UCL

-----

0.265

NRIevent

-----

0.228

NRIevent-LCL

-----

0.184

NRInonevent-UCL

-----

0.038

NRInonevent

-----

0.008

NRInonevent-LCL

-----

-0.024
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A.4 Missing data analyses simulation (third aim)
A.4.1 Description (missdat_sim)
This function compares compares several machine learning and model-based multiple
imputation methods for dealing with missing covariate data under missing completely at
random (MCAR), missing at random (MAR) and missing not at random (MNAR)
scenarios. Beginning with complete case data, the function simulates the desired
missingness scenario, and imputation performance is evaluated using relative bias, root
mean squared error, efficiency and coverage probability statistics.

A.4.2 Usage (missdat_sim)
Missdat_sim(patient_dat, MissType, pctMiss, size, iterations)

A.4.3 Arguments (missdat_sim)
patient_dat

Dataframe containing the outcome and covariates such as race,
age, gender, marital status, and clinical variables. Categorical
variables should be stored as factors.

MissType

The missingness pattern to be simulated in patient_dat. The
options are “MCAR”, “MAR”, “MNAR”. See details (below) for
further information concerning the missingness scenarios.

pctMiss

The fraction of patients in the bootstrapped dataset with any
missing value. Options are restricted to .1, .3, and .5.
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iterations

The number of bootstrapped training and validation samples to be
generated in order to determine the distribution of the comparison
statistics.

size

The number of observations within each bootstrapped sample.

A.4.4 Details (missdat_sim)
In the example dataset, under MCAR, missingness is generated for race, mean_mpr and
mean_A1c variables completely at random. Under MAR, the probability of missing race
is higher when the patient died, the probability of missing mean_mpr is higher when the
patient is not married, and the probability of missing mean_A1c is greater when the
patient lives in a rural area. Under MNAR, missing race is more likely when the patient is
non-Hispanic black or Hispanic and died; missing mean_mpr is more likely when the
patient’s medication possession ratio (MPR) is above the median value among all
patients; missing mean_A1c is more likely when the patient’s mean A1c level is above
the median value for all patients.

A.4.5 Output objects (missdat_sim)
missdat_sim returns the following objects within a single list:
output

This is a list of dataframes, one per multiple imputation method. Each
provides the performance statistics with 95% confidence limits for that
method, including relative bias, efficiency, root mean squared error, and
coverage probability.
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prob.miss

This provides a list of matrices, one per iteration, that summarizes the
missingness probabilities under each scenario. This permits the user to
verify that the requested scenario was generated.

odd.miss

This provides a list of matrices, one per iteration, that summarizes the
missingness odds ratios for each scenario. Odds ratios are generated
from separate logistic models for each variable with missing values,
where the outcome is a missingness indicator. This permits the user to
verify that the requested scenario was generated.

A.4.6 Example (missdat_sim)
R console output example:
>
>
>
>
>

MissType="MNAR"
pctMiss=.3
Nobs=1000
iterations=1000
missrun<-missdat_sim(dat,MissType,pctMiss,Nobs,iterations)

-----------------> missrun[[1]][[1]]
missType pctMiss MIType
intercept
single1
rural1
rel.bias-median
3
2
1 -0.08798639 -0.01950551 0.2395583
rel.bias-UCL
3
2
1 0.14671663 0.91969042 3.3358113
rel.bias-LCL
3
2
1 -0.34776225 -1.28024266 -1.5368577
ratio_var-median
3
2
1 43.06712909 43.30529920 41.1828111
ratio_var-UCL
3
2
1 46.45898708 46.09625178 42.1956729
ratio_var-LCL
3
2
1 3.00000000 2.00000000 1.0000000
rmse-median
3
2
1 1.67613116 0.31493434 0.2080584
rmse-UCL
3
2
1 2.71125326 0.40489587 0.3515986
rmse-LCL
3
2
1 3.00000000 2.00000000 1.0000000
CovProb-pct
3
2
1 1.00000000 0.66666667 0.6666667
male1
age
race2
race3
race4
rel.bias-median
0.1954343 -0.05470550 -14.729965 -6.3138931 -0.1648961
rel.bias-UCL
0.4009245 0.23325525 -10.182891 -4.6691325 -0.1515784
rel.bias-LCL
-1.4137884 -0.12348141 -16.919479 -7.7017439 -0.2718389
ratio_var-median 39.0422326 41.81670229 199.818772 156.8015798 45.6921451
ratio_var-UCL
44.2419931 44.26315920 434.076280 484.9759815 59.3085076
ratio_var-LCL
-0.3477623 -1.28024266 -1.536858 -1.4137884 -0.1234814
rmse-median
0.6738387 0.01871629
2.659716
2.1834179 0.3735142
rmse-UCL
0.8181008 0.02679147
3.095889
2.7849435 0.4686748
rmse-LCL
3.0000000 2.00000000
1.000000 -0.3477623 -1.2802427
CovProb-pct
1.0000000 1.00000000
0.000000
0.0000000 1.0000000
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meana1c
meanmpr
rel.bias-median
-1.1485749 -0.06151144
rel.bias-UCL
-0.6711596 0.07616864
rel.bias-LCL
-1.2526204 -0.17614600
ratio_var-median 53.8702350 52.63004672
ratio_var-UCL
65.4548691 55.82645845
ratio_var-LCL
-16.9194787 -7.70174393
rmse-median
0.1643232 0.44817799
rmse-UCL
0.1722005 0.63815386
rmse-LCL
-1.5368577 -1.41378845
CovProb-pct
0.6666667 1.00000000

A.5 Sensitivity analyses: selection model
A.5.1 Description
This simulation program written in R implements the method described by Carpenter et
al. for selection model sensitivity analysis after multiple imputation under MAR [36]. The
program in its current form requires the use of the example dataset, patient_dat, which is
stored with the program on GitHub.
A.5.2 Usage
Given the example dataset, a separate function is used to generate MNAR missingness
in the race/ethnicity variable in which race is more likely to be missing in non-Hispanic
blacks and Hispanics who died. These data are then imputed under MAR assumptions
using MICE with logistic regression imputation [26]. Next, the weighted sensitivity
approach is applied through an iterative process to examine candidate values for the
delta vector, which adjusts how strongly a given level of the race variable is associated
with the logodds that it is missing [36]. The user then selects the best values for delta
from these results.
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A.5.3 Arguments
The following arguments must be provided:
patient_dat

Dataframe containing the outcome and covariates such as race,
age, gender, marital status, and clinical variables. Categorical
variables should be stored as factors.

MissType

Must be set to “MNAR” for the purposes of the sensitivity analysis.

pctMiss

The fraction of patients in the bootstrapped dataset with any
missing value. Options are restricted to 0.1, 0.3, and 0.5. Default
value is 0.3.

delta

Elements of this vector adjust how strongly a given level of the
race variable is associated with the logodds that it is missing. The
user could optionally adjust the coded values that are iteratively
tested.

A.5.4 Output objects
Output

An output matrix provides a summary of results for each
combination of delta values. These include the estimated race
coefficients under MNAR, with relative bias, efficiency, root mean
squared error and coverage probability provided for each. Finally,
the mortality odds ratios for the MNAR coefficient estimates are
provided.
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Weights

This is a list, with a separate matrix for each iteration, providing
the calculated weights. See Carpenter et al. [36]for further
information on the weights.

A.6 Sensitivity analyses: pattern mixture model
A.6.1 Description
This SAS program demonstrates the method for adjusting each level of the imputed
race/ethnicity variables using pattern mixture models [32]. For now, it requires the use
of the provided example dataset.

A.6.2 Usage
The demonstration includes three macros which work together:
%macro missgen

This macro generates MNAR missingness for the race
variable in the provided SAS dataset (simdat). See
sections A.4 and A.5 for more information on the MNAR
association. The macro requires a separately provided
SAS program file (missgen.sas) be available. The user
should modify the first line of the macro to indicate where
this file is stored. The SAS dataset simdat must be loaded
in the user’s SAS work directory.

%macro tune

This macro uses SAS PROC MI to perform multiple
imputations with pattern mixture model adjustments. Four
inputs are required (variables zero, one, two, three); these
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are the adjustments to each of the race/ethnicity variables.
PROC GENMOD and PROC MIANALYZE are then used
to analyze and combine the multiple imputation results.
%macro shell

This macro helps the user to iteratively determine the best
combination of the four race/ethnicity adjustment
parameters. For the range of selected values and for the
total number of desired iterations, each combination of
adjustments is tested using the %missgen and %tune
macros.

A.6.4 Output objects
The results of %shell are stored in two files found in the work directory:
results_freq

This table provides the race distribution for each imputed
dataset after MNAR adjustment.

results_OR

This table provides the results for each combination of the
adjustment parameters. Provided results include
parameter estimates and their standard errors, the
mortality odds ratio and 95% confidence limits, relative
bias, efficiency, root mean squared error, and coverage
probability.
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